Dow (DOW) 10-Q 1 May 20 2020 Q1 Quarterly report Financial data

Cover Page

Cover Page	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Shell Company	false
Entity Interactive Data Current	Yes
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Information [Line Items]
Entity Registrant Name	Dow Inc.
Entity Tax Identification Number	30-1128146
Entity File Number	001-38646
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Central Index Key	0001751788
Current Fiscal Year End Date	--12-31
Entity Addresses [Line Items]
Entity Address, Address Line One	2211 H.H. Dow Way
Entity Address, City or Town	Midland
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48674
City Area Code	989
Local Phone Number	636-1000
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	DOW
Security Exchange Name	NYSE
Entity Listing, Par Value Per Share | $ / shares	$ 0.01
Entity Common Stock, Shares Outstanding | shares	740,730,813
The Dow Chemical Company [Domain]
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Shell Company	false
Entity Interactive Data Current	Yes
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Information [Line Items]
Entity Registrant Name	The Dow Chemical Company
Entity Tax Identification Number	38-1285128
Entity File Number	001-03433
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Central Index Key	0000029915
Current Fiscal Year End Date	--12-31
Entity Addresses [Line Items]
Entity Address, Address Line One	2211 H.H. Dow Way
Entity Address, City or Town	Midland
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48674
City Area Code	989
Local Phone Number	636-1000
Entity Listings [Line Items]
Entity Listing, Par Value Per Share | $ / shares	$ 0.01
Entity Common Stock, Shares Outstanding | shares	100
The Dow Chemical Company [Domain] | 0.500% Notes due March 15, 2027
Entity Listings [Line Items]
Title of 12(b) Security	0.500% Notes due March 15, 2027
Trading Symbol	DOW/27
Security Exchange Name	NYSE
The Dow Chemical Company [Domain] | 1.125% Notes due March 15, 2032
Entity Listings [Line Items]
Title of 12(b) Security	1.125% Notes due March 15, 2032
Trading Symbol	DOW/32
Security Exchange Name	NYSE
The Dow Chemical Company [Domain] | 1.875% Notes due March 15, 2040
Entity Listings [Line Items]
Title of 12(b) Security	1.875% Notes due March 15, 2040
Trading Symbol	DOW/40
Security Exchange Name	NYSE
The Dow Chemical Company [Domain] | 4.625% Notes due October 1, 2044
Entity Listings [Line Items]
Title of 12(b) Security	4.625% Notes due October 1, 2044
Trading Symbol	DOW/44
Security Exchange Name	NYSE

Dow Consolidated Statements of

Dow Consolidated Statements of Income Statement - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net sales	$ 9,770	$ 10,969
Cost of sales	8,230	9,142
Research and development expenses	179	190
Selling, general and administrative expenses	334	448
Amortization of intangibles	100	116
Restructuring and asset related charges - net	96	156
Integration and separation costs	65	452
Equity in losses of nonconsolidated affiliates	(89)	(14)
Sundry income (expense) - net	(81)	69
Interest income	15	18
Interest expense and amortization of debt discount	215	241
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	396	297
Provision for income taxes on continuing operations	138	141
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	258	156
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Net income	258	601
Net income attributable to noncontrolling interests	19	45
Net income available for Dow Inc. common stockholders	$ 239	$ 556
Earnings per common share from continuing operations - basic	$ 0.32	$ 0.16
Earnings per common share from discontinued operations - basic	0	0.58
Earnings per common share - basic	0.32	0.74
Earnings per common share from continuing operations - diluted	0.32	0.16
Earnings per common share from discontinued operations - diluted	0	0.58
Earnings per common share - diluted	$ 0.32	$ 0.74
Weighted-average common shares outstanding - basic	740.2	747.2
Weighted-average common shares outstanding - diluted	742	747.2
Depreciation	$ 515	$ 543
Capital expenditures	$ 395	$ 442

Dow Consolidated Statements o_2

Dow Consolidated Statements of Comprehensive Income Statement - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 258	$ 601
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(100)	67
Cumulative translation adjustments	(163)	(31)
Pension and other postretirement benefit plans	142	141
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(162)	(75)
Other Comprehensive Income (Loss), Net of Tax	(283)	102
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	(25)	703
Comprehensive income attributable to noncontrolling interests, net of tax	19	51
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ (44)	$ 652

Dow Consolidated Balance Sheets

Dow Consolidated Balance Sheets Statement - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	$ 3,633	$ 2,367
Marketable securities	1	21
Trade (net of allowance for doubtful receivables - 2019: $49; 2018: $42)	4,841	4,844
Other	2,770	2,711
Inventories	6,324	6,214
Other current assets	569	658
Total current assets	18,138	16,815
Investment in nonconsolidated affiliates	1,235	1,404
Other investments	2,136	2,588
Noncurrent receivables	697	1,063
Total investments	4,068	5,055
Property	54,942	54,910
Less accumulated depreciation	34,136	33,914
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	20,806	20,996
Goodwill	8,780	8,796
Other intangible assets (net of accumulated amortization - 2019: $0; 2018: $3,379)	3,636	3,759
Operating lease right-of-use assets	1,942	2,072
Deferred charges and other assets	1,068	818
Total other assets	17,674	17,658
Total Assets	60,686	60,524
Notes payable	1,490	586
Long-term debt due within one year	384	435
Trade	3,769	3,889
Other	1,815	2,064
Operating lease liabilities - current	384	421
Income taxes payable	468	522
Accrued and other current liabilities	2,811	2,762
Total current liabilities	11,121	10,679
Long-term debt	16,313	15,975
Pension and other postretirement benefits - noncurrent	9,832	10,083
Asbestos-related liabilities - noncurrent	1,048	1,060
Operating lease liabilities - noncurrent	1,622	1,739
Other noncurrent obligations	6,937	6,547
Total other noncurrent liabilities	19,791	19,776
Common stock (authorized and issued 100 shares of $0.01 par value each)	8	8
Additional paid-in capital	7,370	7,325
Retained earnings	16,763	17,045
Accumulated other comprehensive loss	(10,529)	(10,246)
Unearned ESOP shares	(81)	(91)
Treasury stock at cost (2020: 12,803,303 shares; 2019: 9,729,834 shares)	(625)	(500)
Dow Inc.’s stockholders’ equity	12,906	13,541
Noncontrolling interests	555	553
Total equity	13,461	14,094
Total Liabilities and Equity	$ 60,686	$ 60,524

Dow Consolidated Balance Shee_2

Dow Consolidated Balance Sheets Parentheticals - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	$ 3,633	$ 2,367
Accounts Receivable, Allowance for Credit Loss, Current	43	45
Investments, Fair Value Disclosure	1,306	1,584
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	20,806	20,996
Finite-Lived Intangible Assets, Accumulated Amortization	3,994	3,886
Long-term debt	$ 16,313	$ 15,975
Common Stock, Shares Authorized	5,000,000,000	5,000,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares, Issued	753,534,116	751,228,644
Treasury Stock, Shares	12,803,303	9,729,834
Other noncurrent assets
Deferred income tax assets	$ 2,248	$ 2,213
Other noncurrent obligations
Deferred income tax liabilities	352	347
Variable Interest Entity, Primary Beneficiary [Member]
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	44	37
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	286	330
Long-term debt	$ 30	$ 34

Dow Consolidated Statements o_3

Dow Consolidated Statements of Cash Flows Statement - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Cash Flows [Abstract]
Net income	$ 258	$ 601
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	258	156
Depreciation and amortization	724	743
Credit for deferred income tax	(57)	(72)
Earnings of nonconsolidated affiliates less than dividends received	134	775
Net periodic pension benefit cost	64	41
Pension contributions	(63)	(99)
Net gain on sales of assets, businesses and investments	(12)	(2)
Restructuring and asset related charges - net	96	156
Other net loss	135	33
Accounts and notes receivable	128	85
Inventories	(111)	(47)
Accounts payable	(314)	(452)
Other assets and liabilities, net	254	(274)
Cash provided by operating activities - continuing operations	1,236	1,043
Cash provided by operating activities - discontinued operations	3	338
Cash provided by operating activities	1,239	1,381
Capital expenditures	(395)	(442)
Investment in gas field developments	(5)	(25)
Proceeds from sales of property and businesses, net of cash divested	11	0
Investments in and loans to nonconsolidated affiliates	(114)	0
Distributions and loan repayments from nonconsolidated affiliates	6	0
Purchases of investments	(128)	(173)
Proceeds from sales and maturities of investments	472	176
Cash used for investing activities - continuing operations	(153)	(464)
Cash used for investing activities - discontinued operations	0	(34)
Cash used for investing activities	(153)	(498)
Changes in short-term notes payable	838	(16)
Proceeds from issuance of long-term debt	2,449	0
Payments on long-term debt	(2,275)	(81)
Purchases of treasury stock	(125)	0
Proceeds from issuance of stock	16	28
Transaction financing, debt issuance and other costs	(93)	0
Employee taxes paid for share-based payment arrangements	(26)	(45)
Distributions to noncontrolling interests	(1)	(2)
Dividends paid to stockholders	(518)	0
Dividends paid to DowDuPont Inc.	0	(535)
Settlements and transfers related to separation from DowDuPont Inc.	0	36
Cash provided by (used for) financing activities - continuing operations	265	(615)
Cash used for financing activities - discontinued operations	0	(18)
Cash provided by (used for) financing activities	265	(633)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(86)	30
Cash reclassified as held for sale	0	(97)
Increase in cash, cash equivalents and restricted cash	1,265	183
Cash, cash equivalents and restricted cash at beginning of period	2,380	2,764
Cash, cash equivalents and restricted cash at end of period	3,645	2,947
Less: Restricted cash and cash equivalents, included in "Other current assets"	12	43
Cash and cash equivalents at end of period	$ 3,633	$ 2,904

Dow Consolidated Statements o_4

Dow Consolidated Statements of Equity Statement - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Unearned ESOP Shares [Member]	Treasury Stock [Member]
Total equity		$ 0	$ 7,042	$ 35,460	$ (9,885)	$ (134)	$ 0
Stock Issued During Period, Value, New Issues and Treasury Stock Reissued			0
Stock Issued During Period, Value, Parent Company Stock			28
APIC, Share-based Payment Arrangement, Increase for Cost Recognition			83			29
Stockholders' Equity, Other				(2)
Net Income (Loss) Available to Common Stockholders, Basic				556
Dividends, Common Stock				0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees				(535)
Settlements and transfers related to separation from DowDuPont Inc.	$ 36			35
Other Comprehensive Income (Loss), Net of Tax	$ 102				102
Treasury Stock, Value, Acquired, Cost Method							0
Common Stock, Dividends, Per Share, Declared	$ 0
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement				(111)
Settlements and transfers related to separation from DowDuPont Inc.				14,806
Dow Inc.’s stockholders’ equity	$ 32,668
Noncontrolling interests	1,180
Total equity	33,848	0	7,153	35,403	(9,783)	(105)	0
Dow Inc.’s stockholders’ equity	13,541
Noncontrolling interests	553
Total equity	14,094	8	7,325	17,045	(10,246)	(91)	(500)
Stock Issued During Period, Value, New Issues and Treasury Stock Reissued			16
Stock Issued During Period, Value, Parent Company Stock			0
APIC, Share-based Payment Arrangement, Increase for Cost Recognition			29			10
Stockholders' Equity, Other				(3)
Net Income (Loss) Available to Common Stockholders, Basic				239
Dividends, Common Stock				(518)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees				0
Settlements and transfers related to separation from DowDuPont Inc.	0			0
Other Comprehensive Income (Loss), Net of Tax	$ (283)				(283)
Treasury Stock, Value, Acquired, Cost Method							(125)
Common Stock, Dividends, Per Share, Declared	$ 0.70
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement				0
Dow Inc.’s stockholders’ equity	$ 12,906
Noncontrolling interests	555
Total equity	$ 13,461	$ 8	$ 7,370	$ 16,763	$ (10,529)	$ (81)	$ (625)

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net sales	$ 9,770	$ 10,969
Cost of sales	8,230	9,142
Research and development expenses	179	190
Selling, general and administrative expenses	334	448
Amortization of intangibles	100	116
Restructuring and asset related charges - net	96	156
Integration and separation costs	65	452
Equity in losses of nonconsolidated affiliates	(89)	(14)
Sundry income (expense) - net	(81)	69
Interest income	15	18
Interest expense and amortization of debt discount	215	241
Income from continuing operations before income taxes	396	297
Provision for income taxes on continuing operations	138	141
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	258	156
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Net income	258	601
Net income attributable to noncontrolling interests	19	45
Net income available for The Dow Chemical Company common stockholder	239	556
Depreciation	515	543
Capital expenditures	395	442
The Dow Chemical Company [Domain]
Net sales	9,770	10,969
Cost of sales	8,230	9,142
Research and development expenses	179	190
Selling, general and administrative expenses	334	448
Amortization of intangibles	100	116
Restructuring and asset related charges - net	96	156
Integration and separation costs	65	452
Equity in losses of nonconsolidated affiliates	(89)	(14)
Sundry income (expense) - net	(82)	69
Interest income	16	18
Interest expense and amortization of debt discount	215	241
Income from continuing operations before income taxes	396	297
Provision for income taxes on continuing operations	138	141
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	258	156
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Net income	258	601
Net income attributable to noncontrolling interests	19	45
Net income available for The Dow Chemical Company common stockholder	239	556
Depreciation	515	543
Capital expenditures	$ 395	$ 442

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net income	$ 258	$ 601
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(100)	67
Cumulative translation adjustments	(163)	(31)
Pension and other postretirement benefit plans	142	141
Derivative instruments	(162)	(75)
Total other comprehensive income (loss)	(283)	102
Comprehensive income (loss)	(25)	703
Comprehensive income attributable to noncontrolling interests, net of tax	19	51
Comprehensive income (loss) attributable to The Dow Chemical Company	(44)	652
The Dow Chemical Company [Domain]
Net income	258	601
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(100)	67
Cumulative translation adjustments	(163)	(31)
Pension and other postretirement benefit plans	142	141
Derivative instruments	(162)	(75)
Total other comprehensive income (loss)	(283)	102
Comprehensive income (loss)	(25)	703
Comprehensive income attributable to noncontrolling interests, net of tax	19	51
Comprehensive income (loss) attributable to The Dow Chemical Company	$ (44)	$ 652

TDCC Consolidated Balance Sheet

TDCC Consolidated Balance Sheets (Statement) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	$ 3,633	$ 2,367
Marketable securities	1	21
Trade (net of allowance for doubtful receivables - 2019: $49; 2018: $42)	4,841	4,844
Other	2,770	2,711
Inventories	6,324	6,214
Other current assets	569	658
Total current assets	18,138	16,815
Investment in nonconsolidated affiliates	1,235	1,404
Other investments	2,136	2,588
Noncurrent receivables	697	1,063
Total investments	4,068	5,055
Property	54,942	54,910
Less accumulated depreciation	34,136	33,914
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	20,806	20,996
Goodwill	8,780	8,796
Other intangible assets (net of accumulated amortization - 2019: $0; 2018: $3,379)	3,636	3,759
Operating lease right-of-use assets	1,942	2,072
Deferred charges and other assets	1,068	818
Total other assets	17,674	17,658
Total Assets	60,686	60,524
Notes payable	1,490	586
Long-term debt due within one year	384	435
Trade	3,769	3,889
Other	1,815	2,064
Operating lease liabilities - current	384	421
Income taxes payable	468	522
Accrued and other current liabilities	2,811	2,762
Total current liabilities	11,121	10,679
Long-term debt	16,313	15,975
Pension and other postretirement benefits - noncurrent	9,832	10,083
Asbestos-related liabilities - noncurrent	1,048	1,060
Operating lease liabilities - noncurrent	1,622	1,739
Other noncurrent obligations	6,937	6,547
Total other noncurrent liabilities	19,791	19,776
Common stock (authorized and issued 100 shares of $0.01 par value each)	8	8
Additional paid-in capital	7,370	7,325
Retained earnings	16,763	17,045
Accumulated other comprehensive loss	(10,529)	(10,246)
Unearned ESOP shares	(81)	(91)
Dow Inc.’s stockholders’ equity	12,906	13,541
Noncontrolling interests	555	553
Total equity	13,461	14,094
Total Liabilities and Equity	60,686	60,524
The Dow Chemical Company [Domain]
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	3,633	2,367
Marketable securities	1	21
Other	2,770	2,716
Inventories	6,324	6,214
Other current assets	490	571
Total current assets	18,059	16,733
Investment in nonconsolidated affiliates	1,235	1,404
Other investments	2,136	2,588
Noncurrent receivables	665	1,011
Total investments	4,036	5,003
Property	54,942	54,910
Less accumulated depreciation	34,136	33,914
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	20,806	20,996
Goodwill	8,780	8,796
Other intangible assets (net of accumulated amortization - 2019: $0; 2018: $3,379)	3,636	3,759
Operating lease right-of-use assets	1,942	2,072
Deferred income tax assets	2,248	2,213
Deferred charges and other assets	1,067	818
Total other assets	17,673	17,658
Total Assets	60,574	60,390
Notes payable	1,490	586
Long-term debt due within one year	384	435
Trade	3,769	3,889
Other	1,815	2,064
Operating lease liabilities - current	384	421
Income taxes payable	468	522
Accrued and other current liabilities	2,314	2,233
Total current liabilities	10,624	10,150
Long-term debt	16,313	15,975
Deferred income tax liabilities	352	347
Pension and other postretirement benefits - noncurrent	9,832	10,083
Asbestos-related liabilities - noncurrent	1,048	1,060
Operating lease liabilities - noncurrent	1,622	1,739
Other noncurrent obligations	6,555	6,174
Total other noncurrent liabilities	19,409	19,403
Common stock (authorized and issued 100 shares of $0.01 par value each)	0	0
Additional paid-in capital	7,378	7,333
Retained earnings	16,905	17,313
Accumulated other comprehensive loss	(10,529)	(10,246)
Unearned ESOP shares	(81)	(91)
Dow Inc.’s stockholders’ equity	13,673	14,309
Noncontrolling interests	555	553
Total equity	14,228	14,862
Total Liabilities and Equity	$ 60,574	$ 60,390

TDCC Consolidated Statements of

TDCC Consolidated Statements of Cash Flows Statement - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Net income	$ 258	$ 601
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	258	156
Depreciation and amortization	724	743
Credit for deferred income tax	(57)	(72)
Earnings of nonconsolidated affiliates less than dividends received	(134)	(775)
Net periodic pension benefit cost	64	41
Pension contributions	(63)	(99)
Net gain on sales of assets, businesses and investments	12	2
Restructuring and asset related charges - net	96	156
Other net loss	(135)	(33)
Accounts and notes receivable	(128)	(85)
Inventories	111	47
Accounts payable	(314)	(452)
Other assets and liabilities, net	(254)	274
Cash provided by operating activities - continuing operations	1,236	1,043
Cash provided by operating activities - discontinued operations	3	338
Cash provided by operating activities	1,239	1,381
Capital expenditures	(395)	(442)
Investment in gas field developments	(5)	(25)
Proceeds from sales of property and businesses, net of cash divested	11	0
Investments in and loans to nonconsolidated affiliates	(114)	0
Distributions and loan repayments from nonconsolidated affiliates	6	0
Purchases of investments	(128)	(173)
Proceeds from sales and maturities of investments	472	176
Cash used for investing activities - continuing operations	(153)	(464)
Cash used for investing activities - discontinued operations	0	(34)
Cash used for investing activities	(153)	(498)
Changes in short-term notes payable	838	(16)
Proceeds from issuance of long-term debt	2,449	0
Payments on long-term debt	(2,275)	(81)
Proceeds from issuance of stock	16	28
Transaction financing, debt issuance and other costs	(93)	0
Employee taxes paid for share-based payment arrangements	(26)	(45)
Distributions to noncontrolling interests	(1)	(2)
Payments of Ordinary Dividends	(518)	0
Dividends paid to DowDuPont Inc.	0	(535)
Settlements and transfers related to separation from DowDuPont Inc.	0	(36)
Cash provided by (used for) financing activities - continuing operations	265	(615)
Cash used for financing activities - discontinued operations	0	(18)
Cash provided by (used for) financing activities	265	(633)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(86)	30
Cash reclassified as held for sale	0	97
Increase in cash, cash equivalents and restricted cash	1,265	183
Cash, cash equivalents and restricted cash at beginning of period	2,380	2,764	$ 2,764
Cash, cash equivalents and restricted cash at end of period	3,645	2,947	2,380
Less: Restricted cash and cash equivalents, included in "Other current assets"	12	43
Cash and cash equivalents at end of period	3,633	2,904	2,367
The Dow Chemical Company [Domain]
Net income	258	601
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	258	156
Depreciation and amortization	724	743
Credit for deferred income tax	(57)	(72)
Earnings of nonconsolidated affiliates less than dividends received	134	775
Net periodic pension benefit cost	64	41
Pension contributions	(63)	(99)
Net gain on sales of assets, businesses and investments	(12)	(2)
Restructuring and asset related charges - net	96	156
Other net loss	136	33
Accounts and notes receivable	128	85
Inventories	(111)	(47)
Accounts payable	(314)	(452)
Other assets and liabilities, net	256	(274)
Cash provided by operating activities - continuing operations	1,239	1,043
Cash provided by operating activities - discontinued operations	0	338
Cash provided by operating activities	1,239	1,381
Capital expenditures	(395)	(442)
Investment in gas field developments	(5)	(25)
Proceeds from sales of property and businesses, net of cash divested	11	0
Investments in and loans to nonconsolidated affiliates	(114)	0
Distributions and loan repayments from nonconsolidated affiliates	6	0
Purchases of investments	(128)	(173)
Proceeds from sales and maturities of investments	472	176
Cash used for investing activities - continuing operations	(153)	(464)
Cash used for investing activities - discontinued operations	0	(34)
Cash used for investing activities	(153)	(498)
Changes in short-term notes payable	838	(16)
Proceeds from issuance of long-term debt	2,449	0
Payments on long-term debt	(2,275)	(81)
Proceeds from issuance of stock	16	28
Transaction financing, debt issuance and other costs	(93)	0
Employee taxes paid for share-based payment arrangements	(26)	(45)
Distributions to noncontrolling interests	(1)	(2)
Payments of Ordinary Dividends	(643)	0
Dividends paid to DowDuPont Inc.	0	(535)
Settlements and transfers related to separation from DowDuPont Inc.	0	36
Cash provided by (used for) financing activities - continuing operations	265	(615)
Cash used for financing activities - discontinued operations	0	(18)
Cash provided by (used for) financing activities	265	(633)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(86)	30
Cash reclassified as held for sale	0	97
Increase in cash, cash equivalents and restricted cash	1,265	183
Cash, cash equivalents and restricted cash at beginning of period	2,380	2,764	2,764
Cash, cash equivalents and restricted cash at end of period	3,645	2,947	2,380
Less: Restricted cash and cash equivalents, included in "Other current assets"	12	43
Cash and cash equivalents at end of period	$ 3,633	$ 2,904	$ 2,367

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss	Unearned ESOP Shares [Member]	The Dow Chemical Company [Domain]	The Dow Chemical Company [Domain]Common Stock [Member]	The Dow Chemical Company [Domain]Additional Paid-in Capital [Member]	The Dow Chemical Company [Domain]Retained Earnings [Member]	The Dow Chemical Company [Domain]Accumulated Other Comprehensive Loss	The Dow Chemical Company [Domain]Unearned ESOP Shares [Member]	The Dow Chemical Company [Domain]Noncontrolling Interests	DowDuPont [Member]Retained Earnings [Member]	Dow Inc. [Member]Retained Earnings [Member]
Total Equity, Beginning at Dec. 31, 2018		$ 0	$ 7,042	$ 35,460	$ (9,885)	$ (134)		$ 0	$ 7,042	$ 35,460	$ (9,885)	$ (134)
Stock Issued									0
Stock-based compensation and allocation of ESOP shares			83			29			83			29
Stock Issued During Period, Value, Parent Company Stock - DWDP			28						28
Net income available for The Dow Chemical Company common stockholder				556						556
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees				(535)										$ (535)	$ 0
Transfer of Business Under Common Control	$ 36			35			$ (36)			35
Other				2						(2)
Other comprehensive income	102				102		102				102
Total Equity, Ending at Mar. 31, 2019	33,848	0	7,153	35,403	(9,783)	(105)	33,848	0	7,153	35,403	(9,783)	(105)	$ 1,180
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement				(111)						(111)
Total Equity, Beginning at Dec. 31, 2018		0	7,042	35,460	(9,885)	(134)		0	7,042	35,460	(9,885)	(134)
Transfer of Business Under Common Control				14,806						16,009
Total Equity, Ending at Dec. 31, 2019	14,094	8	7,325	17,045	(10,246)	(91)	14,862	0	7,333	17,313	(10,246)	(91)
The Dow Chemical Company’s stockholders’ equity	32,668						32,668
The Dow Chemical Company’s stockholders’ equity	13,541						14,309
Stock Issued									16
Stock-based compensation and allocation of ESOP shares			29			10			29			10
Stock Issued During Period, Value, Parent Company Stock - DWDP			0						0
Net income available for The Dow Chemical Company common stockholder				239						239
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees				0										$ 0	$ (643)
Transfer of Business Under Common Control	0			0			0			0
Other				3						(4)
Other comprehensive income	(283)				(283)		(283)				(283)
Total Equity, Ending at Mar. 31, 2020	13,461	$ 8	$ 7,370	16,763	$ (10,529)	$ (81)	14,228	$ 0	$ 7,378	16,905	$ (10,529)	$ (81)	$ 555
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement				$ 0						$ 0
The Dow Chemical Company’s stockholders’ equity	$ 12,906						$ 13,673

Statement of Financial Position

Statement of Financial Position, Classified (Statement) - Retained Earnings [Member] $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
Accounting Standards Update 2014-09 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Period Increase (Decrease)	$ (183)
Accounting Standards Update 2016-02 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Period Increase (Decrease)	$ 72

CONSOLIDATED FINANCIAL STATEMEN

CONSOLIDATED FINANCIAL STATEMENTS	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
CONSOLIDATED FINANCIAL STATEMENTS	CONSOLIDATED FINANCIAL STATEMENTS Merger and Separation On April 1, 2019, DowDuPont Inc. (“DowDuPont” and effective June 3, 2019, n/k/a DuPont de Nemours, Inc. or "DuPont") completed the separation of its materials science business and Dow Inc. became the direct parent company of The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the “Company”). The separation was contemplated by the merger of equals transaction effective August 31, 2017, under the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017. TDCC and E. I. du Pont de Nemours and Company and its consolidated subsidiaries (“Historical DuPont”) each merged with subsidiaries of DowDuPont and, as a result, TDCC and Historical DuPont became subsidiaries of DowDuPont (the “Merger”). Subsequent to the Merger, TDCC and Historical DuPont engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products. Dow Inc. was formed as a wholly owned subsidiary of DowDuPont to serve as the holding company for the materials science business. See Note 3 for additional information. Basis of Presentation The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. Effective April 1, 2019, Dow Inc. owns all of the outstanding common shares of TDCC. TDCC is deemed the predecessor to Dow Inc. and the historical results of TDCC are deemed the historical results of Dow Inc. for periods prior to and including March 31, 2019. As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. As of the effective date and time of the distribution, DowDuPont does not beneficially own any equity interest in Dow and no longer consolidates Dow and its consolidated subsidiaries into its financial results. The consolidated financial results of Dow for all periods presented reflect the distribution of TDCC’s agricultural sciences business (“AgCo”) and specialty products business (“SpecCo”) as discontinued operations, as well as the receipt of Historical DuPont’s ethylene and ethylene copolymers businesses (other than its ethylene acrylic elastomers business) (“ECP”) as a common control transaction from the closing of the Merger on August 31, 2017. See Note 3 for additional information. From the Merger date through the separation, transactions between DowDuPont, TDCC and Historical DuPont and their affiliates were treated as related party transactions. Transactions between TDCC and Historical DuPont primarily consisted of the sale and procurement of certain raw materials that were consumed in each company's manufacturing process. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC. See Note 21 for additional information. Throughout this Quarterly Report on Form 10-Q, unless otherwise indicated, amounts and activity are presented on a continuing operations basis. Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company. Adoption of Accounting Standards In the first quarter of 2019, the Company adopted Accounting Standards Update ("ASU") 2016-02, "Leases (Topic 842)", and the associated ASUs (collectively, "Topic 842"). The net impact to “Retained earnings” was an increase of $72 million and was primarily a result of the recognition of a deferred gain associated with a prior sale-leaseback transaction. See Note 13 for additional information. Additionally, at January 1, 2019, certain nonconsolidated affiliates of the Company, which were subsequently distributed as part of the separation from DowDuPont, adopted ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)" and the associated ASUs (collectively, "Topic 606"). The net impact to "Retained earnings" was a reduction of $183 million at January 1, 2019.

INVENTORIES

INVENTORIES	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES The following table provides a breakdown of inventories: Inventories Mar 31, 2020 Dec 31, 2019 In millions Finished goods $ 3,607 $ 3,505 Work in process 1,080 1,122 Raw materials 590 628 Supplies 860 845 Total $ 6,137 $ 6,100 Adjustment of inventories to a LIFO basis 187 114 Total inventories $ 6,324 $ 6,214

COMMITMENTS AND CONTINGENT LIAB

COMMITMENTS AND CONTINGENT LIABILITIES	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	COMMITMENTS AND CONTINGENT LIABILITIES Environmental Matters Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At March 31, 2020, the Company had accrued obligations of $1,122 million for probable environmental remediation and restoration costs, including $205 million for the remediation of Superfund sites. These obligations are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability. At December 31, 2019, the Company had accrued obligations of $1,155 million for probable environmental remediation and restoration costs, including $207 million for the remediation of Superfund sites. Litigation Asbestos-Related Matters of Union Carbide Corporation A summary of Asbestos-Related Matters of Union Carbide Corporation can be found in Note 17 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. Introduction Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims. Estimating the Asbestos-Related Liability Since 2003, Union Carbide has engaged Ankura Consulting Group, LLC ("Ankura"), a third party actuarial specialist, to review Union Carbide's historical asbestos-related claim and resolution activity in order to assist Union Carbide's management in estimating the asbestos-related liability. Each year, Union Carbide requests Ankura to review its claim and resolution activity, including asbestos-related defense and processing costs, to determine the appropriateness of updating the most recent Ankura study. Based on the review completed by Ankura in December 2019 and Union Carbide's internal review process, Union Carbide's total asbestos-related liability through the terminal year of 2049, including asbestos-related defense and processing costs, was $1,165 million at December 31, 2019, and was included in “Accrued and other current liabilities” and “Asbestos-related liabilities - noncurrent” in the consolidated balance sheets. Each quarter, Union Carbide reviews claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent Ankura study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2020 activity, it was determined that no adjustment to the accrual was required at March 31, 2020. Union Carbide’s asbestos-related liability for pending and future claims and defense and processing costs was $1,148 million at March 31, 2020, and approximately 19 percent of the recorded claim liability related to pending claims and approximately 81 percent related to future claims. Summary The Company's management believes the amounts recorded by Union Carbide for the asbestos-related liability, including defense and processing costs, reflect reasonable and probable estimates of the liability based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of defending and disposing of each such claim, as well as the numerous uncertainties surrounding asbestos litigation in the United States over a significant period of time, could cause the actual costs for Union Carbide to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability. Because of the uncertainties described above, Union Carbide cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. As a result, it is reasonably possible that an additional cost of disposing of Union Carbide's asbestos-related claims, including future defense and processing costs, could have a material impact on the Company's results of operations and cash flows for a particular period and on the consolidated financial position. Dow Silicones Chapter 11 Related Matters A summary of the Dow Silicones Chapter 11 Related Matters can be found in Note 17 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. Introduction In 1995, Dow Silicones, then a 50:50 joint venture between the Company and Corning Incorporated ("Corning"), voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in order to resolve Dow Silicones’ breast implant liabilities and related matters (the “Chapter 11 Proceeding”). Dow Silicones emerged from the Chapter 11 Proceeding on June 1, 2004 and is implementing the Joint Plan of Reorganization (the “Plan”). The Plan provides funding for the resolution of breast implant and other product liability litigation covered by the Chapter 11 Proceeding and provided a process for the satisfaction of commercial creditor claims in the Chapter 11 Proceeding. As of June 1, 2016, Dow Silicones is a wholly owned subsidiary of the Company. Breast Implant and Other Product Liability Claims Under the Plan, a product liability settlement program administered by an independent claims office (the “Settlement Facility”) was created to resolve breast implant and other product liability claims. Dow Silicones has an obligation to fund the Settlement Facility and is expected to make further contributions after the Settlement Facility's existing funds are exhausted. At March 31, 2020, Dow Silicones and its insurers have made life-to-date payments of $1,762 million to the Settlement Facility and the Settlement Facility reported an unexpended balance of $70 million. The claim filing deadline passed in June 2019. All claims have been received by the Settlement Facility and are being processed. Based on the claims filed at and before the deadline, Dow Silicones estimates that it will be obligated to contribute an additional $165 million after the Settlement Facility balance is exhausted. Dow Silicones' Implant Liability was $165 million at March 31, 2020 ($165 million at December 31, 2019), of which $45 million ($20 million at December 31, 2019) was included in “Accrued and other current liabilities” and $120 million ($145 million at December 31, 2019) was included in "Other noncurrent obligations" in the consolidated balance sheets. Dow Silicones is not aware of circumstances that would change the factors used in estimating the Implant Liability and believes the recorded liability reflects the best estimate of the remaining funding obligations under the Plan; however, the estimate relies upon a number of significant assumptions, including: future acceptance rates, disease mix, and payment values will be materially consistent with historical experience; no material negative outcomes in future controversies or disputes over Plan interpretation will occur; and the Plan will not be modified. If actual outcomes related to any of these assumptions prove to be materially different, the future liability to fund the Plan may be materially different than the amount estimated. Summary The amounts recorded by Dow Silicones for the Chapter 11 related matters described above were based on current, known facts, which management believes reflect reasonable and probable estimates of the liability. However, future events could cause the actual costs for Dow Silicones to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability. Other Litigation Matters In addition to the specific matters described above, the Company is party to a number of other claims and lawsuits arising out of the normal course of business with respect to product liability, patent infringement, employment matters, governmental tax and regulation disputes, contract and commercial litigation, and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. The Company has an active risk management program consisting of numerous insurance policies secured from many carriers at various times. These policies may provide coverage that could be utilized to minimize the financial impact, if any, of certain contingencies described above. It is the opinion of the Company’s management that the possibility is remote that the aggregate of all such other claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company. Indemnifications with Corning In connection with the June 1, 2016 ownership restructure of Dow Silicones, the Company is indemnified by Corning for at least 50 percent of future losses associated with certain pre-closing liabilities, including the Implant Liability and certain environmental matters described in the preceding sections, subject to certain conditions and limits. The maximum amount of indemnified losses which may be recovered are subject to a cap that declines over time. The Company had indemnification assets of $100 million at March 31, 2020 ($100 million at December 31, 2019), of which $37 million ($37 million at December 31, 2019) was included in "Other current assets" and $63 million ($63 million at December 31, 2019) was included in "Noncurrent receivables" in the consolidated balance sheets. For additional information, see Note 17 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. Gain Contingency - Dow v. Nova Chemicals Corporation Patent Infringement Matter On December 9, 2010, Dow filed suit in the Federal Court in Ontario, Canada ("Federal Court") alleging that Nova was infringing the Company's Canadian polyethylene patent 2,106,705. Nova counterclaimed on the grounds of invalidity and non-infringement. On June 29, 2017, the Federal Court issued a Confidential Supplemental Judgment, concluding that Nova must pay $645 million Canadian dollars (equivalent to $495 million U.S. dollars) to the Company, plus pre- and post-judgment interest, for which the Company received payment of $501 million from Nova on July 6, 2017. Although Nova is appealing portions of the damages judgment, certain portions of it are indisputable and will be owed to the Company regardless of the outcome of any further appeals by Nova. At March 31, 2020, the Company had $341 million ($341 million at December 31, 2019) included in "Other noncurrent obligations" in the consolidated balance sheets related to the disputed portion of the damages judgment. The Company is confident of its chances of defending the entire judgment on appeal, particularly the trial court's determinations on important factual issues, which will be accorded deferential review on appeal. For additional information, see Note 17 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter On September 18, 2019, the Court of the Queen’s Bench in Alberta, Canada ("Court"), signed a judgment ordering Nova to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars) by October 11, 2019, for damages the Company incurred through 2012 related to the companies’ jointly-owned ethylene asset in Joffre, Alberta, Canada. The Court, which initially ruled in June 2018, found that Nova failed to operate the ethylene asset at full capacity for more than ten years, and furthermore, that Nova violated several contractual agreements related to the Company receiving its share of the asset’s ethylene production. These actions resulted in reduced productivity and sales for the Company. Nova has appealed the judgment, however, certain portions of it are not in dispute and are owed to the Company regardless of the outcome of Nova's appeal. In October 2019, Nova paid $1.08 billion Canadian dollars (equivalent to approximately $0.8 billion U.S. dollars) directly to the Company, and remitted $347 million Canadian dollars to the Canada Revenue Agency ("CRA") for the tax account of one of the Company's subsidiaries. The Company sought a refund of the entire amount remitted to the CRA. On March 31, 2020, the Company received the full refund from CRA, equivalent to $259 million U.S. dollars. At March 31, 2020, $893 million ($893 million at December 31, 2019) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment. Dow is confident of its chances of defending the entire judgment on appeal, particularly the trial court's determinations on important factual and discretionary issues, which will be accorded deferential review on appeal. Guarantees The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for guarantees: Guarantees Mar 31, 2020 Dec 31, 2019 In millions Final Maximum Recorded Final Maximum Recorded Guarantees 2023 $ 3,950 $ 10 2023 $ 3,952 $ 10 Guarantees arise during the ordinary course of business from relationships with customers, committed accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to less than three years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote. The Company has entered into guarantee agreements ("Guarantees") related to project financing for Sadara. The total of an Islamic bond and additional project financing (collectively “Total Project Financing”) obtained by Sadara is approximately $12.5 billion. Sadara had $10.8 billion of Total Project Financing outstanding at March 31, 2020 ($10.8 billion at December 31, 2019). The Company's guaran tee of the Total Project Financing is in proportion to the Company's 35 percent ownership interest in Sadara, or up to approximately $3.9 billion when the project financing is fully drawn. Sadara successfully completed an extensive operational testing program in December 2018, however, the Guarantees will be released upon the satisfactory fulfillment of certain project completion conditions, which is expected by the end of the second quarter of 2020, and must occur no later than December 2020. In the first quarter of 2020, Sadara signed its final logistics service agreement, the final substantive step to project completion.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement [Text Block]	STOCK-BASED COMPENSATION A summary of the Company's stock-based compensation plans can be found in Note 22 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. Stock Incentive Plan The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan. Most of the Company's stock-based compensation awards are granted in the first quarter of each year. In the first quarter of 2020, Dow Inc. granted the following stock-based compensation awards to employees and non-employee directors: • 2.2 million stock options with a weighted-average exercise price of $48.30 per share and a weighted-average fair value of $5.89 per share; • 2.0 million restricted stock units with a weighted-average fair value of $48.00 per share; and • 1.4 million performance stock units with a weighted-average fair value of $48.35 per share.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
VARIABLE INTEREST ENTITIES	VARIABLE INTEREST ENTITIES A summary of the Company's variable interest entities ("VIEs") can be found in Note 25 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. Assets and Liabilities of Consolidated VIEs The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are reflected in “Net income attributable to noncontrolling interests” in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets. The following table summarizes the carrying amounts of these entities' assets and liabilities included in the Company’s consolidated balance sheets at March 31, 2020 and December 31, 2019: Assets and Liabilities of Consolidated VIEs Mar 31, Dec 31, In millions Cash and cash equivalents $ 44 $ 37 Other current assets 52 51 Net property 286 330 Other noncurrent assets 16 18 Total assets 1 $ 398 $ 436 Current liabilities $ 115 $ 141 Long-term debt 30 34 Other noncurrent obligations 19 21 Total liabilities 2 $ 164 $ 196 1. All assets were restricted at March 31, 2020 and December 31, 2019. 2. All liabilities were nonrecourse at March 31, 2020 and December 31, 2019. Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at March 31, 2020 and December 31, 2019 are adjusted for intercompany eliminations and parental guarantees. Nonconsolidated VIEs The following table summarizes the carrying amounts of assets included in the consolidated balance sheets at March 31, 2020 and December 31, 2019, related to variable interests in joint ventures or entities for which the Company is not the primary beneficiary. The Company's maximum exposure to loss is the same as the carrying amounts. Carrying Amounts of Assets Related to Nonconsolidated VIEs Mar 31, Dec 31, In millions Description of asset Silicon joint ventures Equity method investments 1 $ 102 $ 100 1. Classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

INVENTORIES_2

INVENTORIES	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	The following table provides a breakdown of inventories: Inventories Mar 31, 2020 Dec 31, 2019 In millions Finished goods $ 3,607 $ 3,505 Work in process 1,080 1,122 Raw materials 590 628 Supplies 860 845 Total $ 6,137 $ 6,100 Adjustment of inventories to a LIFO basis 187 114 Total inventories $ 6,324 $ 6,214

COMMITMENTS AND CONTINGENT LI_2

COMMITMENTS AND CONTINGENT LIABILITIES	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Table of Guarantees by Type	The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for guarantees: Guarantees Mar 31, 2020 Dec 31, 2019 In millions Final Maximum Recorded Final Maximum Recorded Guarantees 2023 $ 3,950 $ 10 2023 $ 3,952 $ 10

Tables

Tables	3 Months Ended
	Mar. 31, 2020
Variable Interest Entity, Primary Beneficiary [Member]
Schedule of Variable Interest Entities [Table Text Block]	The following table summarizes the carrying amounts of these entities' assets and liabilities included in the Company’s consolidated balance sheets at March 31, 2020 and December 31, 2019: Assets and Liabilities of Consolidated VIEs Mar 31, Dec 31, In millions Cash and cash equivalents $ 44 $ 37 Other current assets 52 51 Net property 286 330 Other noncurrent assets 16 18 Total assets 1 $ 398 $ 436 Current liabilities $ 115 $ 141 Long-term debt 30 34 Other noncurrent obligations 19 21 Total liabilities 2 $ 164 $ 196 1. All assets were restricted at March 31, 2020 and December 31, 2019. 2. All liabilities were nonrecourse at March 31, 2020 and December 31, 2019.
Variable Interest Entity, Not Primary Beneficiary [Member]
Schedule of Variable Interest Entities [Table Text Block]	The following table summarizes the carrying amounts of assets included in the consolidated balance sheets at March 31, 2020 and December 31, 2019, related to variable interests in joint ventures or entities for which the Company is not the primary beneficiary. The Company's maximum exposure to loss is the same as the carrying amounts. Carrying Amounts of Assets Related to Nonconsolidated VIEs Mar 31, Dec 31, In millions Description of asset Silicon joint ventures Equity method investments 1 $ 102 $ 100 1. Classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets.

TDCC Consolidated Balance She_2

TDCC Consolidated Balance Sheets Parentheticals - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	$ 3,633	$ 2,367
Accounts Receivable, Allowance for Credit Loss, Current	43	45
Investments, Fair Value Disclosure	1,306	1,584
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	20,806	20,996
Finite-Lived Intangible Assets, Accumulated Amortization	3,994	3,886
Long-term debt	$ 16,313	$ 15,975
Common Stock, Shares, Issued	753,534,116	751,228,644
Common Stock, Shares Authorized	5,000,000,000	5,000,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
The Dow Chemical Company [Domain]
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	$ 3,633	$ 2,367
Accounts Receivable, Allowance for Credit Loss, Current		45
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	20,806	20,996
Finite-Lived Intangible Assets, Accumulated Amortization		3,886
Long-term debt	$ 16,313	$ 15,975
Common Stock, Shares, Issued	100	100
Common Stock, Shares Authorized	100	100
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Variable Interest Entity, Primary Beneficiary [Member]
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	$ 44	$ 37
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	286	330
Long-term debt	$ 30	$ 34

INVENTORIES (Schedule of Invent

INVENTORIES (Schedule of Inventories) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Finished goods	$ 3,607	$ 3,505
Work in process	1,080	1,122
Raw materials	590	628
Supplies	860	845
Total	6,137	6,100
Adjustment of inventories to a LIFO basis	(187)	(114)
Total inventories	$ 6,324	$ 6,214

COMMITMENTS AND CONTINGENT LI_3

COMMITMENTS AND CONTINGENT LIABILITIES (Environmental Matters) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	$ 1,122	$ 1,155
Accrual For Environmental Loss Contingencies Superfund Sites [Member]
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	$ 205	$ 207

COMMITMENTS AND CONTINGENT LI_4

COMMITMENTS AND CONTINGENT LIABILITIES (Asbestos-Related Matters of Union Carbide Corporation) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Loss Contingencies [Line Items]
Liability for Asbestos and Environmental Claims, Gross	$ 1,148	$ 1,165
Percentage of recorded asbestos liability related to pending claims	19.00%
Percentage of recorded asbestos liability related to future claims	81.00%

COMMITMENTS AND CONTINGENT LI_5

COMMITMENTS AND CONTINGENT LIABILITIES (Guarantees) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Guarantor Obligations [Line Items]
Long-term Debt	$ 16,697	$ 16,410
Sadara Chemical Company [Member]
Guarantor Obligations [Line Items]
Equity Method Investment, Ownership Percentage	35.00%
Sadara Chemical Company [Member] | Total Project Financing [Member]
Guarantor Obligations [Line Items]
Project Financing, Maximum Borrowing Capacity	$ 12,500
Long-term Debt	10,800	10,800
Performance Guarantee [Member]
Guarantor Obligations [Line Items]
Guarantor obligations, maximum future payments	3,950	3,952
Guarantor obligations, recorded liability	10	$ 10
Performance Guarantee [Member] | Sadara Chemical Company [Member]
Guarantor Obligations [Line Items]
Guarantor obligations, maximum future payments	$ 3,900

STOCK-BASED COMPENSATION (Stock

STOCK-BASED COMPENSATION (Stock Incentive Plan) shares in Millions	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares	2.2
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 48.30
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 5.89
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares	2
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 48
Performance Stock Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares	1.4
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 48.35

Schedule of Consolidated VIEs,

Schedule of Consolidated VIEs, Carrying Amounts of Assets and Liabilities - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Variable Interest Entity [Line Items]
Other current assets	$ 569	$ 658
Deferred charges and other assets	1,068	818
Total Assets	60,686	60,524
Accrued and other current liabilities	2,811	2,762
Other noncurrent obligations	6,937	6,547
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	3,633	2,367
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	20,806	20,996
Long-term debt	16,313	15,975
Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Other current assets	52	51
Deferred charges and other assets	16	18
Total Assets	398	436
Accrued and other current liabilities	115	141
Other noncurrent obligations	19	21
Total Liabilities	164	196
Cash and cash equivalents (variable interest entities restricted - 2020: $44; 2019: $37)	44	37
Net property (variable interest entities restricted - 2020: $286; 2019: $330)	286	330
Long-term debt	$ 30	$ 34

Schedule of Nonconsolidated VIE

Schedule of Nonconsolidated VIEs - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Variable Interest Entity [Line Items]
Investment in nonconsolidated affiliates	$ 1,235	$ 1,404
Silicon Inputs Joint Ventures [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Investment in nonconsolidated affiliates	$ 102	$ 100

RECENT ACCOUNTING GUIDANCE

RECENT ACCOUNTING GUIDANCE	3 Months Ended
	Mar. 31, 2020
Accounting Changes and Error Corrections [Abstract]
RECENT ACCOUNTING GUIDANCE	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In the first quarter of 2020, the Company adopted ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement," which is part of the Financial Accounting Standards Board's ("FASB") disclosure framework project to improve the effectiveness of disclosures in the notes to the financial statements. The amendments in the new guidance remove, modify and add certain disclosure requirements related to fair value measurements covered in Topic 820, "Fair Value Measurement." The adoption of this guidance did not have a material impact on the consolidated financial statements. See Note 19 for additional information. In the first quarter of 2020, the Company adopted ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract," which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350, "Intangibles - Goodwill and Other" to determine which implementation costs to capitalize as assets or expense as incurred. The adoption of this guidance did not have a material impact on the consolidated financial statements. In the first quarter of 2020, the Company adopted ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" and the associated ASUs (collectively “Topic 326”). The amendments replace the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Accordingly, companies are required to consider forward-looking information to estimate credit losses expected to occur over the estimated life of an asset, including losses that may be incurred in future periods. The adoption of this guidance did not have a material impact on the consolidated financial statements. Accounting Guidance Issued But Not Adopted at March 31, 2020 In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes." The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, "Income Taxes" and improve consistent application by clarifying and amending existing guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted, with the amendments to be applied on a retrospective, modified retrospective or prospective basis, depending on the specific amendment. The Company is currently evaluating the impact of adopting this guidance. In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The amendments provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments are intended to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting. The new standard is effective March 12, 2020 through December 31, 2022, with the adoption date being dependent upon the Company’s election. The Company is currently evaluating the impact of adopting this guidance.

SEPARATION FROM DOWDUPONT Separ

SEPARATION FROM DOWDUPONT Separation from DowDuPont (Notes)	3 Months Ended
	Mar. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Separation from DowDuPont [Text Block]	SEPARATION FROM DOWDUPONT On April 1, 2019, DowDuPont completed the previously announced separation of its materials science business. The separation was effected by way of a pro rata distribution of all of the then-issued and outstanding shares of Dow Inc. common stock to DowDuPont stockholders of record as of the close of business, Eastern Time, on March 21, 2019 (the “Record Date”). The shareholders of record of DowDuPont received one share of Dow Inc. common stock, par value $0.01 per share, for every three shares of DowDuPont common stock, par value $0.01 per share, held as of the Record Date ("Distribution Ratio"). No fractional shares of Dow Inc. common stock were issued. Instead, cash in lieu of any fractional shares was paid to DowDuPont registered shareholders. The number of shares of Dow Inc. common stock issued on April 1, 2019 was 748.8 million shares. On April 1, 2019, Dow Inc. received a cash contribution of $2,024 million from DowDuPont as part of the internal reorganization and business realignment steps between Dow Inc., TDCC and DowDuPont. Dow Inc. recognized a reduction to "Retained earnings" of $14,806 million in 2019 as a result of the cash contribution, the distribution of AgCo and SpecCo, and other separation related adjustments. TDCC recognized a reduction to "Retained earnings" of $16,009 million in 2019 as a result of the distribution of AgCo and SpecCo. Receipt of ECP As the receipt of ECP was accounted for as a transfer between entities under common control, the consolidated financial statements have been retrospectively adjusted to reflect the receipt of ECP from the closing of the Merger on August 31, 2017. All intercompany transactions have been eliminated in consolidation. The ECP assets received and liabilities assumed were recorded at DowDuPont's historical cost basis. Distribution of AgCo and SpecCo Upon distribution, the Company retrospectively adjusted the previously issued consolidated financial statements and presented AgCo and SpecCo as discontinued operations based on the guidance in Accounting Standards Codification (“ASC”) 205-20 “Discontinued Operations.” The results of operations of AgCo and SpecCo are presented as discontinued operations in the consolidated statements of income and are summarized in the table that follows: Results of Operations of AgCo and SpecCo Three Months Ended Mar 31, 2019 In millions Net sales $ 2,953 Cost of sales 1,804 Research and development expenses 175 Selling, general and administrative expenses 262 Amortization of intangibles 61 Restructuring and asset related charges - net 78 Equity in earnings of nonconsolidated affiliates 28 Sundry income (expense) - net (18) Interest income 3 Interest expense and amortization of debt discount 7 Income from discontinued operations before income taxes $ 579 Provision for income taxes 134 Income from discontinued operations, net of tax $ 445 Agreements Related to the Separation and Distribution In connection with the separation, Dow Inc. entered into certain agreements with DuPont and/or Corteva Inc. ("Corteva"), including the following: Separation and Distribution Agreement, Tax Matters Agreement and Employee Matters Agreement (collectively, the "Agreements"). In addition to establishing the terms of the separation, the Agreements provide a framework for Dow’s interaction with DuPont and Corteva after the separation and also provide for the allocation among Dow, DuPont and Corteva of assets, liabilities and obligations attributable to periods prior to, at and after the completion of the separation. The Agreements also contain certain indemnity and/or cross-indemnity provisions that are intended to set forth each party’s respective rights, responsibilities and obligations for matters subject to indemnification. Except in certain instances, the parties’ indemnification obligations are uncapped. Certain indemnification obligations will be subject to reduction by insurance proceeds or other third-party proceeds of the indemnified party that reduces the amount of the loss. In addition, indemnifiable losses will be subject to, in certain cases, “de minimis” threshold amounts and, in certain cases, deductible amounts. The impacts of indemnifications and other post-separation matters relating to the Agreements were primarily reflected in the consolidated financial statements of Dow Inc. At March 31, 2020, the Company had assets of $51 million ($58 million at December 31, 2019) included in "Other current assets" and $32 million ($52 million at December 31, 2019) included in "Noncurrent receivables," and liabilities of $319 million ($352 million at December 31, 2019) included in "Accrued and other current liabilities" and $105 million ($96 million at December 31, 2019) included in "Other noncurrent obligations" in the consolidated balance sheets of Dow Inc. related to the Agreements. Any adjustments to these assets and liabilities in subsequent periods will be recorded in Dow Inc.'s results of operations. In addition, the Company deferred approximately $400 million of the cash distribution received from DowDuPont at separation and recorded an associated liability in "Other noncurrent obligations," with an offset to "Retained earnings" in the consolidated balance sheets of Dow Inc. At March 31, 2020,$130 million ($130 million at December 31, 2019) of this liability was recorded in "Accrued and other current liabilities" and $270 million ($270 million at December 31, 2019) was recorded in "Other noncurrent obligations" in the consolidated balance sheets. The final resolution of this liability is uncertain and any subsequent adjustments to the carrying value of this liability will be reflected in equity of Dow Inc. In the first quarter of 2020, Dow Inc. received a net payment of $6 million related to the Agreements, with $3 million recorded in "Cash flows from operating activities - discontinued operations" and $3 million recorded in "Other assets and liabilities, net" within "Cash flows from operating activities - continuing operations" in the Dow Inc. consolidated statements of cash flows. Integration and Separation Costs Integration and separation costs, which reflect costs related to business separation activities, were $65 million for Dow Inc. and TDCC in the first quarter of 2020, compared with $452 million in the first quarter of 2019. Integration and separation costs related to business separation activities are expected to be substantially complete by the end of 2020.

REVENUE (Notes)

REVENUE (Notes)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	REVENUE Revenue Recognition The majority of Dow's revenue is derived from product sales. In the three months ended March 31, 2020, 99 percent of Dow's revenue related to product sales (99 percent for the three months ended March 31, 2019), with the remaining balance primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of Dow's products to manufacturers and distributors and considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. Dow enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from Dow’s licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract. Remaining Performance Obligations Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At March 31, 2020, Dow had unfulfilled performance obligations of $829 million ($826 million at December 31, 2019) related to the licensing of technology. Dow expects revenue to be recognized for the remaining performance obligations over the next seven years. The remaining performance obligations are for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which Dow has elected the right to invoice practical expedient, or variable consideration attributable to royalties for licenses of patents and technology. Dow has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 21 years. Dow will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets. Disaggregation of Revenue Dow disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. Net Trade Sales by Segment and Business Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Hydrocarbons & Energy $ 1,219 $ 1,404 Packaging and Specialty Plastics 3,390 3,734 Packaging & Specialty Plastics $ 4,609 $ 5,138 Industrial Solutions $ 1,054 $ 1,127 Polyurethanes & Construction Chemicals 1,988 2,350 Other 3 3 Industrial Intermediates & Infrastructure $ 3,045 $ 3,480 Coatings & Performance Monomers $ 828 $ 902 Consumer Solutions 1,237 1,380 Performance Materials & Coatings $ 2,065 $ 2,282 Corporate $ 51 $ 69 Total $ 9,770 $ 10,969 Net Trade Sales by Geographic Region Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 U.S. & Canada $ 3,550 $ 3,933 EMEAI 1 3,411 3,882 Asia Pacific 1,845 2,101 Latin America 964 1,053 Total $ 9,770 $ 10,969 1. Europe, Middle East, Africa and India. Contract Assets and Liabilities Dow receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to Dow's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract. Revenue recognized in the first three months of 2020 from amounts included in contract liabilities at the beginning of the period was approximately $35 million (approximately $55 million in the first three months of 2019). In the first three months of 2020, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was approximately $10 million ($15 million in the first three months of 2019). The following table summarizes the contract assets and liabilities at March 31, 2020 and December 31, 2019: Contract Assets and Liabilities Mar 31, 2020 Dec 31, 2019 In millions Accounts and notes receivable - Trade $ 4,841 $ 4,844 Contract assets - current 1 $ 22 $ 41 Contract assets - noncurrent 2 $ 17 $ 4 Contract liabilities - current 3 $ 196 $ 193 Contract liabilities - noncurrent 4 $ 1,602 $ 1,607 1. Included in "Other current assets" in the consolidated balance sheets. 2. Included in "Deferred charges and other assets" in the consolidated balance sheets. 3. Included in "Accrued and other current liabilities" in the consolidated balance sheets. 4. Included in "Other noncurrent obligations" in the consolidated balance sheets.

RESTRUCTURING AND ASSET RELATED

RESTRUCTURING AND ASSET RELATED CHARGES - NET (Notes)	3 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	RESTRUCTURING AND ASSET RELATED CHARGES - NET Charges for restructuring programs and other asset related charges, which includes other asset impairments, were $96 million for the three months ended March 31, 2020 ($156 million for the three months ended March 31, 2019). These charges were recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. Restructuring Plans DowDuPont Cost Synergy Program In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the "Synergy Program") wh ich was designed to integrate and optimize the organization following the Merger and in preparation for the business separations. In the first quarter of 2020, the Company recorded pretax restructuring charges of $90 million for severance and related benefit costs. These are the final charges related to restructuring actions under the DowDuPont Cost Synergy Program. The Company expects cash expenditures related to the Synergy Program to be substantially complete by the end of 2020. The following table summarizes the activities related to the Synergy Program, which are reflected on a continuing operations basis: DowDuPont Synergy Program Severance and Related Benefit Costs Asset Write-downs and Write-offs Costs Associated with Exit and Disposal Activities Total In millions Reserve balance at Dec 31, 2018 $ 210 $ — $ 7 $ 217 Packaging & Specialty Plastics $ — $ — $ 1 $ 1 Corporate 52 76 15 143 Total restructuring charges $ 52 $ 76 $ 16 $ 144 Charges against the reserve — (76) — (76) Cash payments (79) — (4) (83) Reserve balance at Mar 31, 2019 $ 183 $ — $ 19 $ 202 Performance Materials & Coatings $ — $ 22 $ — $ 22 Corporate 25 7 5 37 Total restructuring charges $ 25 $ 29 $ 5 $ 59 Charges against the reserve — (29) — (29) Cash payments (71) — (2) (73) Reserve balance at Jun 30, 2019 $ 137 $ — $ 22 $ 159 Industrial Intermediates & Infrastructure $ — $ — $ 5 $ 5 Performance Materials & Coatings — 1 — 1 Corporate 46 4 — 50 Total restructuring charges $ 46 $ 5 $ 5 $ 56 Charges against the reserve — (5) — (5) Cash payments (77) — (6) (83) Reserve balance at Sep 30, 2019 $ 106 $ — $ 21 $ 127 Industrial Intermediates & Infrastructure $ — $ 2 $ — $ 2 Performance Materials & Coatings — 5 — 5 Corporate — 26 — 26 Total restructuring charges $ — $ 33 $ — $ 33 Charges against the reserve — (33) — (33) Cash payments (52) — (4) (56) Reserve balance at Dec 31, 2019 $ 54 $ — $ 17 $ 71 Corporate $ 90 $ — $ — $ 90 Total restructuring charges $ 90 $ — $ — $ 90 Cash payments (42) — (1) (43) Reserve balance at Mar 31, 2020 $ 102 $ — $ 16 $ 118 At March 31, 2020, $104 million of the reserve balance was included in "Accrued and other current liabilities" ($52 million at December 31, 2019) and $14 million was included in "Other noncurrent obligations" ($19 million at December 31, 2019) in the consolidated balance sheets. The Company recorded pretax restructuring charges of $965 million inception-to-date under the Synergy Program on a continuing operations basis, consisting of severance and related benefit costs of $657 million, asset write-downs and write-offs of $263 million and costs associated with exit and disposal activities of $45 million. Asset Write-downs and Write-offs The restructuring charges related to the write-down and write-off of assets related primarily to miscellaneous asset write-downs and write-offs, including the shutdown of several small manufacturing facilities and the write-off of non-manufacturing assets and certain corporate facilities. Costs Associated with Exit and Disposal Activities The restructuring charges for costs associated with exit and disposal activities included contract cancellation penalties and environmental remediation liabilities. The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities and restructuring plan implementation costs; these costs will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time. Asset Related Charges The Company recognized an additional pretax impairment charge of $6 million for the three months ended March 31, 2020, related to capital additions made to a biopolymers manufacturing facility in Santa Vitoria, Minas Gerais, Brazil, which was impaired in 2017 (charge of $12 million for the three months ended March 31, 2019). The impairment charge was included in “Restructuring and asset related charges - net” in the consolidated statements of income and related to Packaging & Specialty Plastics. See Note 19 for additional information.

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplementary Information Disclosure [Text Block]	SUPPLEMENTARY INFORMATION The Company uses "Sundry income (expense) – net" to record a variety of income and expense items such as foreign currency exchange gains and losses, dividends from investments, gains and losses on sales of investments and assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters. For the three months ended March 31, 2020, "Sundry income (expense) - net" was expense of $81 million for Dow Inc. and expense of $82 million for TDCC compared with income of $69 million for the three months ended March 31, 2019. "Sundry income (expense) - net" decreased primarily due to an $86 million loss on the early extinguishment of debt (related to Corporate) and foreign currency exchange losses for the three months ended March 31, 2020 compared with foreign currency exchange gains for the three months ended March 31, 2019, as well as a decrease in non-operating pension and postretirement benefit plan credits. See Notes 11, 16 and 22 for additional information. Other Investments The Company has investments in company-owned life insurance ("COLI") policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below: Investments in Company-owned Life Insurance Mar 31, 2020 Dec 31, 2019 In millions Gross cash value $ 828 $ 820 Less: Existing drawdowns 1 $ 287 $ 85 Investment in Company-owned life insurance 2 $ 541 $ 735 1. Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows. 2. Classified as "Other investments" in the consolidated balance sheets.

EARNINGS PER SHARE (Notes)

EARNINGS PER SHARE (Notes)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS PER SHARE CALCULATIONS The following tables provide earnings per share calculations for Dow Inc. for the three months ended March 31, 2020 and 2019. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries. Net Income for Earnings Per Share Calculations Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Income from continuing operations, net of tax $ 258 $ 156 Net income attributable to noncontrolling interests - continuing operations 19 32 Net income attributable to participating securities - continuing operations 1 2 — Income from continuing operations attributable to common stockholders $ 237 $ 124 Income from discontinued operations, net of tax $ — $ 445 Net income attributable to noncontrolling interests - discontinued operations — 13 Income from discontinued operations attributable to common stockholders $ — $ 432 Net income attributable to common stockholders $ 237 $ 556 Earnings Per Share Calculations - Basic Three Months Ended Dollars per share Mar 31, 2020 Mar 31, 2019 Income from continuing operations attributable to common stockholders $ 0.32 $ 0.16 Income from discontinued operations attributable to common stockholders — 0.58 Net income attributable to common stockholders $ 0.32 $ 0.74 Earnings Per Share Calculations - Diluted Three Months Ended Dollars per share Mar 31, 2020 Mar 31, 2019 Income from continuing operations attributable to common stockholders $ 0.32 $ 0.16 Income from discontinued operations attributable to common stockholders — 0.58 Net income attributable to common stockholders $ 0.32 $ 0.74 Share Count Information Three Months Ended Shares in millions Mar 31, 2020 Mar 31, 2019 Weighted-average common shares - basic 2 740.2 747.2 Plus dilutive effect of equity compensation plans 1.8 — Weighted-average common shares - diluted 2 742.0 747.2 Stock options and restricted stock units excluded from EPS calculations 3 15.5 — 1. Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares. 2. Share amounts for the three months ended March 31, 2019, were based on 2,246.3 million DowDuPont common shares outstanding as of the Record Date for the April 1, 2019 distribution, less 4.6 million Employee Stock Ownership Plan ("ESOP") shares that had not been released and were not considered outstanding, adjusted for the Distribution Ratio. There was no dilutive effect for the three months ended March 31, 2019, as the Company did not engage in activities giving rise to dilution. 3. These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. For the three months ended March 31, 2019, the Company did not engage in activities giving rise to dilution.

NONCONSOLIDATED AFFILIATES

NONCONSOLIDATED AFFILIATES	3 Months Ended
	Mar. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]
NONCONSOLIDATED AFFILIATES	NONCONSOLIDATED AFFILIATES The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets, are shown in the following table: Investments in Nonconsolidated Affiliates Mar 31, 2020 Dec 31, 2019 In millions Investment in nonconsolidated affiliates $ 1,235 $ 1,404 Other noncurrent obligations (317) (80) Net investment in nonconsolidated affiliates $ 918 $ 1,324 In March 2020, The Kuwait Styrene Company K.S.C.C. paid a dividend of $42 million, reflected in "Earnings of nonconsolidated affiliates less than dividends received" in the consolidated statements of cash flows. At March 31, 2020, the Company had $276 million included in "Accounts and notes receivable - Other" in the consolidated balance sheets related to the Company's share of dividends declared by EQUATE Petrochemical Company K.S.C.C. ("EQUATE") and The Kuwait Olefins Company K.S.C.C. At March 31, 2020, the Company had a negative investment balance in EQUATE of $225 million (negative $80 million at December 31, 2019), classified as "Other noncurrent obligations" in the consolidated balance sheets. At March 31, 2020, the Company had a negative investment balance in Sadara Chemical Company (“Sadara”) of $92 million (zero at December 31, 2019) classified as “Other noncurrent obligations” in the Company’s consolidated balance sheets, primarily related to the Company’s share of Sadara’s accumulated other comprehensive loss from the first quarter of 2020. The Company’s investment in Sadara was other-than-temporarily impaired in the fourth quarter of 2019 and Dow will continue to recognize its share of equity losses reported by Sadara due to funding commitments. For additional information, see Note 13 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	GOODWILL AND OTHER INTANGIBLE ASSETS The following table shows changes in the carrying amount of goodwill by reportable segment: Goodwill Packaging & Specialty Plastics Industrial Intermediates & Infrastructure Performance Materials & Coatings Total In millions Net goodwill at Dec 31, 2019 $ 5,109 $ 1,100 $ 2,587 $ 8,796 Foreign currency impact (1) (1) (14) (16) Net goodwill at Mar 31, 2020 $ 5,108 $ 1,099 $ 2,573 $ 8,780 The following table provides information regarding the Company’s other intangible assets: Other Intangible Assets Mar 31, 2020 Dec 31, 2019 In millions Gross Accum Net Gross Accum Net Intangible assets with finite lives: Developed technology $ 2,636 $ (1,518) $ 1,118 $ 2,634 $ (1,467) $ 1,167 Software 1,458 (915) 543 1,449 (893) 556 Trademarks/tradenames 352 (342) 10 352 (342) 10 Customer-related 3,184 (1,219) 1,965 3,207 (1,184) 2,023 Total other intangible assets, finite lives $ 7,630 $ (3,994) $ 3,636 $ 7,642 $ (3,886) $ 3,756 In-process research and development — — — 3 — 3 Total other intangible assets $ 7,630 $ (3,994) $ 3,636 $ 7,645 $ (3,886) $ 3,759 The following table provides information regarding amortization expense from continuing operations related to intangible assets: Amortization Expense from Continuing Operations Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Other intangible assets, excluding software $ 100 $ 116 Software, included in “Cost of sales” $ 24 $ 24 Total estimated amortization expense from continuing operations for 2020 and the five succeeding fiscal years, including amounts expected to be capitalized, is as follows: Estimated Amortization Expense from Continuing Operations In millions 2020 $ 491 2021 $ 467 2022 $ 404 2023 $ 372 2024 $ 354 2025 $ 266

NOTES PAYABLE, LONG-TERM DEBT A

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES	NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Notes Payable Mar 31, Dec 31, In millions Commercial paper $ 250 $ 151 Notes payable to banks and other lenders 1 1,240 435 Total notes payable $ 1,490 $ 586 Period-end average interest rates 3.78 % 6.30 % 1. Includes $800 million drawn from uncommitted facilities in the first quarter of 2020. Long-Term Debt 2020 Average Rate Mar 31, 2019 Dec 31, In millions Promissory notes and debentures: Final maturity 2020 8.44 % $ 76 8.44 % $ 76 Final maturity 2021 8.95 % 173 8.95 % 174 Final maturity 2022 8.64 % 121 3.50 % 1,372 Final maturity 2023 7.64 % 325 7.64 % 325 Final maturity 2024 3.37 % 1,397 3.37 % 1,397 Final maturity 2025 5.26 % 662 5.26 % 662 Final maturity 2026 and thereafter 5.73 % 8,888 5.73 % 8,820 Other facilities: U.S. dollar loans 1.74 % 1,250 2.55 % 2,000 Foreign currency notes and loans, various rates and maturities 1.41 % 3,040 3.26 % 592 InterNotes®, varying maturities through 2050 3.44 % 702 3.44 % 928 Finance lease obligations 1 418 395 Unamortized debt discount and issuance costs (355) (331) Long-term debt due within one year 2 (384) (435) Long-term debt $ 16,313 $ 15,975 1. See Note 13 for additional information. 2. Presented net of current portion of unamortized debt issuance costs. Maturities of Long-Term Debt for Next Five Years at Mar 31, 2020 In millions 2020 $ 359 2021 $ 491 2022 $ 225 2023 1 $ 1,693 2024 $ 1,504 2025 $ 780 1. Assumes the option to extend will be exercised for the $1.25 billion Dow Silicones Term Loan Facility. 2020 Activity In February 2020, the Company issued €2.25 billion aggregate principal amount of notes (“Euro Notes”). The Euro Notes included €1.0 billion aggregate principal amount of 0.50 percent notes due 2027, €750 million aggregate principal amount of 1.125 percent notes due 2032 and €500 million aggregate principal amount of 1.875 percent notes due 2040. The Euro Notes have a weighted average coupon rate of approximately 1.0 percent. With the net proceeds from the issuance of the Euro Notes, Dow Silicones voluntarily repaid $750 million of principal under a certain third party credit agreement (“Term Loan Facility”). In addition, the Company redeemed $1.25 billion of 3.0 percent notes issued by the Company with maturity in 2022. As a result, the Company recognized a pretax loss of $85 million on the early extinguishment of debt, included in “Sundry income (expense) – net” in the consolidated statements of income and related to the Corporate segment. At March 31, 2020, the Company's outstanding withdrawal amount under various uncommitted bilateral credit arrangements was $800 million, included in "Notes payable" in the consolidated balance sheets. In the first three months of 2020, the Company also issued an aggregate principal amount of $37 million of InterNotes®, and redeemed an aggregate principal amount of $62 million at maturity. In addition, the Company voluntarily repaid an aggregate principal amount of $200 million of InterNotes® with various maturities. As a result, the Company recognized a pretax loss of $1 million on the early extinguishment of debt, included in “Sundry income (expense) – net” in the consolidated statements of income and related to the Corporate segment. 2019 Activity In the first three months of 2019, the Company redeemed an aggregate principal amount of $72 million of InterNotes® at maturity. Available Credit Facilities The following table summarizes the Company's credit facilities: Committed and Available Credit Facilities at Mar 31, 2020 In millions Committed Credit Credit Available Maturity Date Interest Five Year Competitive Advance and Revolving Credit Facility $ 5,000 $ 5,000 October 2024 Floating rate Term Loan Facility 1 1,250 — September 2023 Floating rate European Securitization Facility 2 440 440 October 2020 Floating rate Bilateral Revolving Credit Facility 200 200 July 2020 Floating rate Bilateral Revolving Credit Facility 100 100 August 2020 Floating rate Bilateral Revolving Credit Facility 300 300 December 2020 Floating rate Bilateral Revolving Credit Facility 300 300 December 2021 Floating rate Bilateral Revolving Credit Facility 150 150 March 2022 Floating rate Bilateral Revolving Credit Facility 100 100 October 2024 Floating rate Bilateral Revolving Credit Facility 100 100 October 2024 Floating rate Bilateral Revolving Credit Facility 200 200 November 2024 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 250 250 March 2025 Floating rate Bilateral Revolving Credit Facility 275 275 March 2025 Floating rate Total committed and available credit facilities $ 8,765 $ 7,515 1. Assumes the option to extend the Term Loan Facility will be exercised. 2. Equivalent to €400 million. Debt Covenants and Default Provisions

LEASES (Notes)

LEASES (Notes)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases of Lessee Disclosure [Text Block]	LEASES For additional information on the Company's leases, see Note 18 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. The components of lease cost for operating and finance leases for the three months ended March 31, 2020 and 2019 were as follows: Lease Cost Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Operating lease cost $ 120 $ 125 Finance lease cost Amortization of right-of-use assets - finance $ 13 $ 6 Interest on lease liabilities - finance 6 6 Total finance lease cost $ 19 $ 12 Short-term lease cost 54 50 Variable lease cost 64 44 Sublease income (1) (1) Total lease cost $ 256 $ 230 The following table provides supplemental cash flow information related to leases: Other Lease Information Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 126 $ 133 Operating cash flows for finance leases $ 6 $ 6 Financing cash flows for finance leases $ 8 $ 3 The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at March 31, 2020 and December 31, 2019: Lease Position Balance Sheet Classification Mar 31, 2020 Dec 31, 2019 In millions Right-of-use assets obtained in exchange for lease obligations: Operating leases 1 $ 38 $ 2,476 Finance leases $ 34 $ 89 Assets Operating lease assets Operating lease right-of-use assets $ 1,942 $ 2,072 Finance lease assets Property 526 486 Finance lease amortization Accumulated depreciation (179) (167) Total lease assets $ 2,289 $ 2,391 Liabilities Current Operating Operating lease liabilities - current $ 384 $ 421 Finance Long-term debt due within one year 49 32 Noncurrent Operating Operating lease liabilities - noncurrent 1,622 1,739 Finance Long-Term Debt 369 363 Total lease liabilities $ 2,424 $ 2,555 1. Includes $2.3 billion for the period ended December 31, 2019 related to the adoption of Topic 842. Lease Term and Discount Rate Mar 31, 2020 Dec 31, 2019 Weighted-average remaining lease term Operating leases 8.0 years 8.0 years Finance leases 11.5 years 12.3 years Weighted-average discount rate Operating leases 4.10 % 4.09 % Finance leases 6.04 % 6.28 % The following table provides the maturities of lease liabilities at March 31, 2020: Maturities of Lease Liabilities Mar 31, 2020 Operating Leases Finance Leases In millions 2020 $ 338 $ 56 2021 409 64 2022 349 57 2023 281 82 2024 218 29 2025 and thereafter 806 310 Total future undiscounted lease payments $ 2,401 $ 598 Less imputed interest 395 180 Total present value of lease liabilities $ 2,006 $ 418 At March 31, 2020, Dow had additional leases of approximately $65 million, primarily for buildings, a rail yard and equipment, which had not yet commenced. These leases are expected to commence in 2020 and 2021, with lease terms of up to 20 years. Dow provides guarantees related to certain leased assets, specifying the residual value that will be available to the lessor at lease termination through the sale of the assets to the lessee or third parties. The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for residual value guarantees at March 31, 2020 and December 31, 2019. There was no recorded liability related to these residual value guarantees at March 31, 2020 or December 31, 2019, as payment of such residual value guarantees was not determined to be probable. The lease agreements do not contain any material restrictive covenants. Lease Guarantees Mar 31, 2020 Dec 31, 2019 In millions Final Expiration Maximum Future Payments Recorded Liability Final Expiration Maximum Future Payments Recorded Liability Residual value guarantees 2028 $ 788 $ — 2028 $ 792 $ —

Equity

Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	ACCUMULATED OTHER COMPREHENSIVE LOSS The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2020 and 2019 were as follows: Accumulated Other Comprehensive Loss Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Unrealized Gains (Losses) on Investments Beginning balance $ 64 $ (51) Unrealized gains (losses) on investments (118) 86 Less: Tax (expense) benefit 25 (18) Net unrealized gains (losses) on investments (93) 68 (Gains) losses reclassified from AOCL to net income 1 (9) (1) Less: Tax expense (benefit) 2 2 — Net (gains) losses reclassified from AOCL to net income (7) (1) Other comprehensive income (loss), net of tax (100) 67 Ending balance $ (36) $ 16 Cumulative Translation Adjustment Beginning balance $ (1,135) $ (1,813) Gains (losses) on foreign currency translation (161) (12) Less: Tax (expense) benefit 12 (1) Net gains (losses) on foreign currency translation (149) (13) (Gains) losses reclassified from AOCL to net income 3 (14) (18) Other comprehensive income (loss), net of tax (163) (31) Ending balance $ (1,298) $ (1,844) Pension and Other Postretirement Benefits Beginning balance $ (8,781) $ (7,965) Amortization and recognition of net loss and prior service credits 4 185 166 Less: Tax expense (benefit) 2 (43) (25) Other comprehensive income (loss), net of tax 142 141 Ending balance $ (8,639) $ (7,824) Derivative Instruments Beginning balance $ (394) $ (56) Gains (losses) on derivative instruments (176) (95) Less: Tax (expense) benefit 10 27 Net gains (losses) on derivative instruments (166) (68) (Gains) losses reclassified from AOCL to net income 5 7 (7) Less: Tax expense (benefit) 2 (3) — Net (gains) losses reclassified from AOCL to net income 4 (7) Other comprehensive income (loss), net of tax (162) (75) Ending balance $ (556) $ (131) Total AOCL ending balance $ (10,529) $ (9,783) 1. Reclassified to "Net sales" and "Sundry income (expense) - net." 2. Reclassified to "Provision for income taxes on continuing operations." 3. Reclassified to "Sundry income (expense) - net." 4. These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note 16 for additional information. 5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

NONCONTROLLING INTERESTS Noncon

NONCONTROLLING INTERESTS Noncontrolling Interests	3 Months Ended
	Mar. 31, 2020
Noncontrolling Interest [Abstract]
Noncontrolling Interest Disclosure [Text Block]	NONCONTROLLING INTERESTS Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income. The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2020 and 2019: Noncontrolling Interests Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Balance at beginning of period $ 553 $ 1,138 Net income attributable to noncontrolling interests - continuing operations 19 32 Net income attributable to noncontrolling interests - discontinued operations — 13 Distributions to noncontrolling interests 1 (1) (9) Cumulative translation adjustments (16) 7 Other — (1) Balance at end of period $ 555 $ 1,180 1. Includes amounts attributable to discontinued operations of $7 million for the three months ended March 31, 2019.

PENSION PLANS AND OTHER POSTRET

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS	3 Months Ended
	Mar. 31, 2020
Retirement Benefits [Abstract]
PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS	PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS A summary of the Company's pension and other postretirement benefit plans can be found in Note 21 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. The following table provides the components of the Company's net periodic benefit cost for all significant plans: Net Periodic Benefit Cost for All Significant Plans Three Months Ended In millions Mar 31, Mar 31, Defined Benefit Pension Plans: Service cost $ 99 $ 112 Interest cost 192 241 Expected return on plan assets (414) (417) Amortization of prior service credit (5) (6) Amortization of net loss 192 132 Net periodic benefit cost $ 64 $ 62 Less: Discontinued operations — 21 Net periodic benefit cost - continuing operations $ 64 $ 41 Other Postretirement Benefit Plans: Service cost $ 2 $ 2 Interest cost 9 14 Amortization of net gain (2) (6) Net periodic benefit cost $ 9 $ 10 Net periodic benefit cost, other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income. The Company's funding policy is to contribute to defined benefit pension plans in the United States and a number of other countries when pension laws and/or economics either require or encourage fund ing. The Company expects to contribute approximately $290 million to its pension plans in 2020, of which $63 million has been contributed through March 31, 2020.

Financial Instruments

Financial Instruments	3 Months Ended
	Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Financial Instruments	FINANCIAL INSTRUMENTS A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 23 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. The following table summarizes the fair value of financial instruments at March 31, 2020 and December 31, 2019: Fair Value of Financial Instruments Mar 31, 2020 Dec 31, 2019 In millions Cost Gain Loss Fair Value Cost Gain Loss Fair Value Cash equivalents: Held-to-maturity securities 1 $ 1,233 $ — $ — $ 1,233 $ 220 $ — $ — $ 220 Money market funds 573 — — 573 408 — — 408 Total cash equivalents $ 1,806 $ — $ — $ 1,806 $ 628 $ — $ — $ 628 Marketable securities $ 1 $ — $ — $ 1 $ 21 $ — $ — $ 21 Other investments: Debt securities: Government debt 2 $ 458 $ 37 $ (33) $ 462 $ 533 $ 33 $ (11) $ 555 Corporate bonds 877 43 (84) 836 944 80 (10) 1,014 Total debt securities $ 1,335 $ 80 $ (117) $ 1,298 $ 1,477 $ 113 $ (21) $ 1,569 Equity securities 3 8 1 (1) 8 10 6 (1) 15 Total other investments $ 1,343 $ 81 $ (118) $ 1,306 $ 1,487 $ 119 $ (22) $ 1,584 Total cash equivalents, marketable securities and other investments $ 3,150 $ 81 $ (118) $ 3,113 $ 2,136 $ 119 $ (22) $ 2,233 Long-term debt including debt due within one year 4 $ (16,697) $ 384 $ (1,326) $ (17,639) $ (16,410) $ 7 $ (2,258) $ (18,661) Derivatives relating to: Interest rates 5 $ — $ 194 $ (331) $ (137) $ — $ 8 $ (283) $ (275) Foreign currency — 53 (39) 14 — 101 (21) 80 Commodities 5 — 133 (286) (153) — 59 (115) (56) Total derivatives $ — $ 380 $ (656) $ (276) $ — $ 168 $ (419) $ (251) 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations. 3. Equity securities with a readily determinable fair value. 4. Cost includes fair value hedge adjustment gains of $68 million at March 31, 2020 and $1 million at December 31, 2019 on $2,790 million of debt at March 31, 2020 and $3,490 million of debt at December 31, 2019. 5. Presented net of cash collateral where master netting arrangements allow. Cost approximates fair value for all other financial instruments. Debt Securities The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides the investing results from available-for-sale securities for the three months ended March 31, 2020 and 2019: Investing Results Three Months Ended In millions Mar 31, Mar 31, Proceeds from sales of available-for-sale securities $ 248 $ 159 Gross realized gains $ 16 $ 6 Gross realized losses $ (7) $ (5) The following table summarizes the contractual maturities of the Company's investments in debt securities: Contractual Maturities of Debt Securities at Mar 31, 2020 1 Cost Fair Value In millions Within one year $ 12 $ 11 One to five years 363 340 Six to ten years 467 437 After ten years 493 510 Total $ 1,335 $ 1,298 1. Includes marketable securities with maturities of less than one year. The following table provides the fair value and gross unrealized losses of the Company’s investments in debt securities that were deemed to be temporarily impaired at March 31, 2020 and December 31, 2019, aggregated by investment category: Temporarily Impaired Debt Securities Less than 12 months 12 months or more Total Fair Unrealized Fair Unrealized Fair Value Unrealized Losses In millions Mar 31, 2020 Government debt 1 $ 109 $ (22) $ 10 $ (11) $ 119 $ (33) Corporate bonds 407 (66) 24 (18) 431 (84) Total temporarily impaired debt securities $ 516 $ (88) $ 34 $ (29) $ 550 $ (117) Dec 31, 2019 Government debt 1 $ 55 $ (3) $ 23 $ (8) $ 78 $ (11) Corporate bonds 79 (3) 52 (7) 131 (10) Total temporarily impaired debt securities $ 134 $ (6) $ 75 $ (15) $ 209 $ (21) 1. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities' obligations. Equity Securities There were no material adjustments to the carrying value of the not readily determinable investments, for impairment or observable price changes, for the three months ended March 31, 2020. The net unrealized loss recognized in earnings on equity securities totaled $1 million for the three months ended March 31, 2020 ($5 million net unrealized gain for the three months ended March 31, 2019). Investments in Equity Securities Mar 31, 2020 Dec 31, 2019 In millions Readily determinable fair value $ 8 $ 15 Not readily determinable fair value $ 190 $ 189 Derivative Instruments The notional amounts of the Company's derivative instruments presented on a net basis at March 31, 2020 and December 31, 2019 were as follows: Notional Amounts - Net Mar 31, 2020 Dec 31, 2019 In millions Derivatives designated as hedging instruments: Interest rate contracts $ 921 $ 922 Foreign currency contracts $ 3,472 $ 6,253 Derivatives not designated as hedging instruments: Interest rate contracts $ 105 $ 145 Foreign currency contracts $ 5,706 $ 5,567 The notional amounts of the Company's commodity derivatives presented on a net basis at March 31, 2020 and December 31, 2019 were as follows: Commodity Notionals - Net Mar 31, 2020 Dec 31, 2019 Notional Volume Unit Derivatives designated as hedging instruments: Hydrocarbon derivatives 20.0 6.1 million barrels of oil equivalent Derivatives not designated as hedging instruments: Hydrocarbon derivatives 0.4 0.1 million barrels of oil equivalent Power derivatives 80.5 87.5 thousands of megawatt hours Maturity Dates of Derivatives Designated as Hedging Instruments Year Interest rate contracts 2021 Foreign currency contracts 2021 Commodity contracts 2022 The following tables provide the fair value and balance sheet classification of derivative instruments at March 31, 2020 and December 31, 2019: Fair Value of Derivative Instruments Mar 31, 2020 In millions Balance Sheet Classification Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheets Asset derivatives Derivatives designated as hedging instruments: Interest rate contracts Other current assets $ 192 $ (156) $ 36 Foreign currency contracts Other current assets 109 (80) 29 Commodity contracts Other current assets 82 (32) 50 Commodity contracts Deferred charges and other assets 67 (3) 64 Total $ 450 $ (271) $ 179 Derivatives not designated as hedging instruments: Interest rate contracts Deferred charges and other assets $ 158 $ — $ 158 Foreign currency contracts Other current assets 65 (41) 24 Commodity contracts Other current assets 22 (4) 18 Commodity contracts Deferred charges and other assets 1 — 1 Total $ 246 $ (45) $ 201 Total asset derivatives $ 696 $ (316) $ 380 Liability derivatives Derivatives designated as hedging instruments: Interest rate contracts Accrued and other current liabilities $ 156 $ (156) $ — Foreign currency contracts Accrued and other current liabilities 88 (80) 8 Commodity contracts Accrued and other current liabilities 152 (32) 120 Commodity contracts Other noncurrent obligations 148 (3) 145 Total $ 544 $ (271) $ 273 Derivatives not designated as hedging instruments: Interest rate contracts Other noncurrent obligations $ 331 $ — $ 331 Foreign currency contracts Accrued and other current liabilities 71 (40) 31 Commodity contracts Accrued and other current liabilities 24 (4) 20 Commodity contracts Other noncurrent obligations 1 — 1 Total $ 427 $ (44) $ 383 Total liability derivatives $ 971 $ (315) $ 656 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Fair Value of Derivative Instruments Dec 31, 2019 In millions Balance Sheet Classification Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheets Asset derivatives Derivatives designated as hedging instruments: Interest rate contracts Other current assets $ 21 $ (13) $ 8 Foreign currency contracts Other current assets 105 (36) 69 Commodity contracts Other current assets 44 (25) 19 Commodity contracts Deferred charges and other assets 28 (3) 25 Total $ 198 $ (77) $ 121 Derivatives not designated as hedging instruments: Interest rate contracts Other current assets $ 14 $ (14) $ — Foreign currency contracts Other current assets 44 (12) 32 Commodity contracts Other current assets 18 (3) 15 Total $ 76 $ (29) $ 47 Total asset derivatives $ 274 $ (106) $ 168 Liability derivatives Derivatives designated as hedging instruments: Interest rate contracts Accrued and other current liabilities $ 23 $ (13) $ 10 Interest rate contracts Other noncurrent obligations 1 — 1 Foreign currency contracts Accrued and other current liabilities 46 (36) 10 Commodity contracts Accrued and other current liabilities 95 (29) 66 Commodity contracts Other noncurrent obligations 38 (4) 34 Total $ 203 $ (82) $ 121 Derivatives not designated as hedging instruments: Interest rate contracts Accrued and other current liabilities $ 136 $ (14) $ 122 Interest rate contracts Other noncurrent obligations 150 — 150 Foreign currency contracts Accrued and other current liabilities 23 (12) 11 Commodity contracts Accrued and other current liabilities 17 (3) 14 Commodity contracts Other noncurrent obligations 1 — 1 Total $ 327 $ (29) $ 298 Total liability derivatives $ 530 $ (111) $ 419 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $6 million at March 31, 2020 ($5 million at December 31, 2019). Counterparties posted cash collateral of $1 million with the Company at March 31, 2020 ($3 million at December 31, 2019).

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	FAIR VALUE MEASUREMENTS A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 24 to the Consolidated Financial Statements included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2019. Fair Value Measurements on a Recurring Basis The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis: Basis of Fair Value Measurements on a Recurring Basis Mar 31, 2020 Dec 31, 2019 Quoted Prices in Active Markets for Identical Items Significant Other Observable Inputs Total Quoted Prices in Active Markets for Identical Items Significant Other Observable Inputs Total In millions Assets at fair value Cash equivalents Held-to-maturity securities 1 $ — $ 1,233 $ 1,233 $ — $ 220 $ 220 Money market funds — 573 573 — 408 408 Marketable securities — 1 1 — 21 21 Equity securities 2 8 — 8 15 — 15 Debt securities: 2 Government debt 3 — 462 462 — 555 555 Corporate bonds 20 816 836 22 992 1,014 Derivatives relating to: 4 Interest rates — 350 350 — 35 35 Foreign currency — 174 174 — 149 149 Commodities 31 141 172 23 67 90 Total assets at fair value $ 59 $ 3,750 $ 3,809 $ 60 $ 2,447 $ 2,507 Liabilities at fair value Long-term debt including debt due within one year 5 $ — $ 17,639 $ 17,639 $ — $ 18,661 $ 18,661 Derivatives relating to: 4 Interest rates — 487 487 — 310 310 Foreign currency — 159 159 — 69 69 Commodities 18 307 325 14 137 151 Total liabilities at fair value $ 18 $ 18,592 $ 18,610 $ 14 $ 19,177 $ 19,191 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets. 3. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations. 4. See Note 18 for the classification of derivatives in the consolidated balance sheets. 5. See Note 18 for information on fair value measurements of long-term debt. For equity securities calculated at net asset value per share (or its equivalent), the Company had $114 million in private market securities and $22 million in real estate at March 31, 2020 ($117 million in private market securities and $18 million in real estate at December 31, 2019). There are no redemption restrictions and the unfunded commitments on these investments were $66 million at March 31, 2020 ($76 million at December 31, 2019). Fair Value Measurements on a Nonrecurring Basis In the first three months of 2020, the Company recognized an additional pretax impairment charge of $6 million related to capital additions made to the biopolymers manufacturing facility in Santa Vitoria, Minas Gerais, Brazil, which was impaired in 2017. The assets were written down to zero in 2020. The impairment charge was included in “Restructuring and asset related charges - net” in the consolidated statements of income and related to Packaging & Specialty Plastics. See Note 5 for additional information.

RELATD PARTY TRANSACTIONS (Note

RELATD PARTY TRANSACTIONS (Notes)	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	RELATED PARTY TRANSACTIONS Effective with the separation from DowDuPont on April 1, 2019, TDCC became a wholly owned subsidiary of Dow Inc. and reported transactions with Dow Inc. as related party transactions. From the Merger date through March 31, 2019, TDCC reported transactions with DowDuPont and Historical DuPont and its affiliates as related party transactions. TDCC TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders and share repurchases, as approved by Dow Inc.'s Board of Directors from time to time, as well as certain governance expenses. Funding is accomplished through intercompany loans. TDCC's Board reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans. In the first quarter of 2020, TDCC declared and paid a dividend of $643 million to Dow Inc. (zero in the first quarter of 2019). TDCC's outstanding intercompany loan balance with Dow Inc. was insignificant at March 31, 2020 and December 31, 2019. DowDuPont Pursuant to the Merger Agreement, TDCC committed to fund a portion of DowDuPont's dividends paid to common stockholders and certain governance expenses. In addition, share repurchases by DowDuPont were partially funded by TDCC through 2018. For the three months ended March 31, 2019, TDCC declared and paid dividends to DowDuPont of $535 million. Historical DuPont and its affiliates Prior to the separation from DowDuPont, TDCC sold to and procured from Historical DuPont and its affiliates certain raw materials that were consumed in each company's manufacturing process. The following table presents revenue earned and expenses incurred related to transactions with Historical DuPont and its affiliates: Sales to Historical DuPont and its Affiliates Three months ended In millions Mar 31, Net sales $ 12 Cost of sales $ 9 Purchases from Historical DuPont and its affiliates were insignificant for the three months ended March 31, 2019.

SEGMENTS AND GEOGRAPHIC REGIONS

SEGMENTS AND GEOGRAPHIC REGIONS (Notes)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segments and Geographic Regions [Text Block]	SEGMENTS AND GEOGRAPHIC REGIONS Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT (for the three months ended March 31, 2020) and pro forma Operating EBIT (for the three months ended March 31, 2019) as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income from continuing operations before income taxes") before interest, excluding the impact of significant items. The Company defines pro forma Operating EBIT as earnings (i.e., "Income from continuing operations before income taxes") before interest, plus pro forma adjustments, excluding the impact of significant items. Operating EBIT and pro forma Operating EBIT by segment include all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate. The Company also presents pro forma net sales for the three months ended March 31, 2019 in this footnote as it is included in management's measure of segment performance and is regularly reviewed by the CODM. Pro forma net sales includes the impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont. Segment Information Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Three months ended Mar 31, 2020 Net sales $ 4,609 $ 3,045 $ 2,065 $ 51 $ 9,770 Equity in earnings (losses) of nonconsolidated affiliates 5 (76) 1 (19) (89) Dow Inc. Operating EBIT 1 580 175 162 (74) 843 Three months ended Mar 31, 2019 Net sales $ 5,138 $ 3,480 $ 2,282 $ 69 $ 10,969 Pro forma net sales 5,138 3,489 2,320 69 11,016 Equity in earnings (losses) of nonconsolidated affiliates 38 (48) — (4) (14) Dow Inc. pro forma Operating EBIT 2 690 277 271 (95) 1,143 1. Operating EBIT for TDCC for the three months ended March 31, 2020 is substantially the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Income from continuing operations, net of tax" to Operating EBIT is provided on the following page. 2. Pro forma Operating EBIT for TDCC for the three months ended March 31, 2019 is the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Income from continuing operations, net of tax" to pro forma Operating EBIT is provided on the following page. Reconciliation of "Income from continuing operations, net of tax" to Operating EBIT Three Months Ended In millions Mar 31, 2020 Income from continuing operations, net of tax $ 258 + Provision for income taxes on continuing operations 138 Income from continuing operations before income taxes $ 396 - Interest income 15 + Interest expense and amortization of debt discount 215 - Significant items (247) Operating EBIT $ 843 Reconciliation of "Income from continuing operations, net of tax" to Pro Forma Operating EBIT Three Months Ended In millions Mar 31, 2019 Income from continuing operations, net of tax $ 156 + Provision for income taxes on continuing operations 141 Income from continuing operations before income taxes $ 297 - Interest income 18 + Interest expense and amortization of debt discount 241 + Pro forma adjustments 1 65 - Significant items (558) Pro forma Operating EBIT $ 1,143 1. Pro forma adjustments include (1) the margin impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont and (2) the elimination of the impact of events directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs). The following tables summarize the pretax impact of significant items by segment that are excluded from Operating EBIT and pro forma Operating EBIT: Significant Items by Segment Three Months Ended Mar 31, 2020 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Mat. & Coatings Corp. Total In millions Integration and separation costs 1 $ — $ — $ — $ (65) $ (65) Restructuring and asset related charges - net 2 (6) — — (90) (96) Loss on early extinguishment of debt 3 — — — (86) (86) Total $ (6) $ — $ — $ (241) $ (247) 1. Costs related to business separation activities. 2. Includes Board approved restructuring plans and asset related charges, which include other asset impairments. See Note 5 for additional information. 3. The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 11 for additional information. Significant Items by Segment Three Months Ended Mar 31, 2019 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Mat. & Coatings Corp. Total In millions Integration and separation costs 1 $ — $ — $ — $ (402) $ (402) Restructuring and asset related charges - net 2 (13) — — (143) (156) Total $ (13) $ — $ — $ (545) $ (558) 1. Costs related to business separation activities. Excludes one-time transaction costs directly attributable to the Merger.

SEPARATION FROM DOWDUPONT Sep_2

SEPARATION FROM DOWDUPONT Separation from DowDuPont (Tables)	3 Months Ended
	Mar. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Schedule of income (loss) from discontinued operations [Table Text Block]	The results of operations of AgCo and SpecCo are presented as discontinued operations in the consolidated statements of income and are summarized in the table that follows: Results of Operations of AgCo and SpecCo Three Months Ended Mar 31, 2019 In millions Net sales $ 2,953 Cost of sales 1,804 Research and development expenses 175 Selling, general and administrative expenses 262 Amortization of intangibles 61 Restructuring and asset related charges - net 78 Equity in earnings of nonconsolidated affiliates 28 Sundry income (expense) - net (18) Interest income 3 Interest expense and amortization of debt discount 7 Income from discontinued operations before income taxes $ 579 Provision for income taxes 134 Income from discontinued operations, net of tax $ 445

REVENUE (Tables)

REVENUE (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table Text Block]	Dow disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. Net Trade Sales by Segment and Business Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Hydrocarbons & Energy $ 1,219 $ 1,404 Packaging and Specialty Plastics 3,390 3,734 Packaging & Specialty Plastics $ 4,609 $ 5,138 Industrial Solutions $ 1,054 $ 1,127 Polyurethanes & Construction Chemicals 1,988 2,350 Other 3 3 Industrial Intermediates & Infrastructure $ 3,045 $ 3,480 Coatings & Performance Monomers $ 828 $ 902 Consumer Solutions 1,237 1,380 Performance Materials & Coatings $ 2,065 $ 2,282 Corporate $ 51 $ 69 Total $ 9,770 $ 10,969 Net Trade Sales by Geographic Region Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 U.S. & Canada $ 3,550 $ 3,933 EMEAI 1 3,411 3,882 Asia Pacific 1,845 2,101 Latin America 964 1,053 Total $ 9,770 $ 10,969 1. Europe, Middle East, Africa and India.
Contract with Customer, Asset and Liability [Table Text Block]	The following table summarizes the contract assets and liabilities at March 31, 2020 and December 31, 2019: Contract Assets and Liabilities Mar 31, 2020 Dec 31, 2019 In millions Accounts and notes receivable - Trade $ 4,841 $ 4,844 Contract assets - current 1 $ 22 $ 41 Contract assets - noncurrent 2 $ 17 $ 4 Contract liabilities - current 3 $ 196 $ 193 Contract liabilities - noncurrent 4 $ 1,602 $ 1,607 1. Included in "Other current assets" in the consolidated balance sheets. 2. Included in "Deferred charges and other assets" in the consolidated balance sheets. 3. Included in "Accrued and other current liabilities" in the consolidated balance sheets. 4. Included in "Other noncurrent obligations" in the consolidated balance sheets.

Restructuring and Related Activ

Restructuring and Related Activities (Tables)	3 Months Ended
	Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	The following table summarizes the activities related to the Synergy Program, which are reflected on a continuing operations basis: DowDuPont Synergy Program Severance and Related Benefit Costs Asset Write-downs and Write-offs Costs Associated with Exit and Disposal Activities Total In millions Reserve balance at Dec 31, 2018 $ 210 $ — $ 7 $ 217 Packaging & Specialty Plastics $ — $ — $ 1 $ 1 Corporate 52 76 15 143 Total restructuring charges $ 52 $ 76 $ 16 $ 144 Charges against the reserve — (76) — (76) Cash payments (79) — (4) (83) Reserve balance at Mar 31, 2019 $ 183 $ — $ 19 $ 202 Performance Materials & Coatings $ — $ 22 $ — $ 22 Corporate 25 7 5 37 Total restructuring charges $ 25 $ 29 $ 5 $ 59 Charges against the reserve — (29) — (29) Cash payments (71) — (2) (73) Reserve balance at Jun 30, 2019 $ 137 $ — $ 22 $ 159 Industrial Intermediates & Infrastructure $ — $ — $ 5 $ 5 Performance Materials & Coatings — 1 — 1 Corporate 46 4 — 50 Total restructuring charges $ 46 $ 5 $ 5 $ 56 Charges against the reserve — (5) — (5) Cash payments (77) — (6) (83) Reserve balance at Sep 30, 2019 $ 106 $ — $ 21 $ 127 Industrial Intermediates & Infrastructure $ — $ 2 $ — $ 2 Performance Materials & Coatings — 5 — 5 Corporate — 26 — 26 Total restructuring charges $ — $ 33 $ — $ 33 Charges against the reserve — (33) — (33) Cash payments (52) — (4) (56) Reserve balance at Dec 31, 2019 $ 54 $ — $ 17 $ 71 Corporate $ 90 $ — $ — $ 90 Total restructuring charges $ 90 $ — $ — $ 90 Cash payments (42) — (1) (43) Reserve balance at Mar 31, 2020 $ 102 $ — $ 16 $ 118

SUPPLEMENTARY INFORMATION (Tabl

SUPPLEMENTARY INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Company-Owned Life Insurance	The Company has investments in company-owned life insurance ("COLI") policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below: Investments in Company-owned Life Insurance Mar 31, 2020 Dec 31, 2019 In millions Gross cash value $ 828 $ 820 Less: Existing drawdowns 1 $ 287 $ 85 Investment in Company-owned life insurance 2 $ 541 $ 735 1. Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows. 2. Classified as "Other investments" in the consolidated balance sheets.

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following tables provide earnings per share calculations for Dow Inc. for the three months ended March 31, 2020 and 2019. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries. Net Income for Earnings Per Share Calculations Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Income from continuing operations, net of tax $ 258 $ 156 Net income attributable to noncontrolling interests - continuing operations 19 32 Net income attributable to participating securities - continuing operations 1 2 — Income from continuing operations attributable to common stockholders $ 237 $ 124 Income from discontinued operations, net of tax $ — $ 445 Net income attributable to noncontrolling interests - discontinued operations — 13 Income from discontinued operations attributable to common stockholders $ — $ 432 Net income attributable to common stockholders $ 237 $ 556 Earnings Per Share Calculations - Basic Three Months Ended Dollars per share Mar 31, 2020 Mar 31, 2019 Income from continuing operations attributable to common stockholders $ 0.32 $ 0.16 Income from discontinued operations attributable to common stockholders — 0.58 Net income attributable to common stockholders $ 0.32 $ 0.74 Earnings Per Share Calculations - Diluted Three Months Ended Dollars per share Mar 31, 2020 Mar 31, 2019 Income from continuing operations attributable to common stockholders $ 0.32 $ 0.16 Income from discontinued operations attributable to common stockholders — 0.58 Net income attributable to common stockholders $ 0.32 $ 0.74 Share Count Information Three Months Ended Shares in millions Mar 31, 2020 Mar 31, 2019 Weighted-average common shares - basic 2 740.2 747.2 Plus dilutive effect of equity compensation plans 1.8 — Weighted-average common shares - diluted 2 742.0 747.2 Stock options and restricted stock units excluded from EPS calculations 3 15.5 — 1. Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares. 2. Share amounts for the three months ended March 31, 2019, were based on 2,246.3 million DowDuPont common shares outstanding as of the Record Date for the April 1, 2019 distribution, less 4.6 million Employee Stock Ownership Plan ("ESOP") shares that had not been released and were not considered outstanding, adjusted for the Distribution Ratio. There was no dilutive effect for the three months ended March 31, 2019, as the Company did not engage in activities giving rise to dilution. 3. These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. For the three months ended March 31, 2019, the Company did not engage in activities giving rise to dilution.

NONCONSOLIDATED AFFILIATES (Tab

NONCONSOLIDATED AFFILIATES (Tables)	3 Months Ended
	Mar. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]
Nonconsolidated Affiliates - Investments	The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by classification in the consolidated balance sheets, are shown in the following table: Investments in Nonconsolidated Affiliates Mar 31, 2020 Dec 31, 2019 In millions Investment in nonconsolidated affiliates $ 1,235 $ 1,404 Other noncurrent obligations (317) (80) Net investment in nonconsolidated affiliates $ 918 $ 1,324

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of goodwill	The following table shows changes in the carrying amount of goodwill by reportable segment: Goodwill Packaging & Specialty Plastics Industrial Intermediates & Infrastructure Performance Materials & Coatings Total In millions Net goodwill at Dec 31, 2019 $ 5,109 $ 1,100 $ 2,587 $ 8,796 Foreign currency impact (1) (1) (14) (16) Net goodwill at Mar 31, 2020 $ 5,108 $ 1,099 $ 2,573 $ 8,780
Schedule of other intangible assets	The following table provides information regarding the Company’s other intangible assets: Other Intangible Assets Mar 31, 2020 Dec 31, 2019 In millions Gross Accum Net Gross Accum Net Intangible assets with finite lives: Developed technology $ 2,636 $ (1,518) $ 1,118 $ 2,634 $ (1,467) $ 1,167 Software 1,458 (915) 543 1,449 (893) 556 Trademarks/tradenames 352 (342) 10 352 (342) 10 Customer-related 3,184 (1,219) 1,965 3,207 (1,184) 2,023 Total other intangible assets, finite lives $ 7,630 $ (3,994) $ 3,636 $ 7,642 $ (3,886) $ 3,756 In-process research and development — — — 3 — 3 Total other intangible assets $ 7,630 $ (3,994) $ 3,636 $ 7,645 $ (3,886) $ 3,759
Schedule of amortization expense	The following table provides information regarding amortization expense from continuing operations related to intangible assets: Amortization Expense from Continuing Operations Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Other intangible assets, excluding software $ 100 $ 116 Software, included in “Cost of sales” $ 24 $ 24
Schedule of estimated future amortization expense	Total estimated amortization expense from continuing operations for 2020 and the five succeeding fiscal years, including amounts expected to be capitalized, is as follows: Estimated Amortization Expense from Continuing Operations In millions 2020 $ 491 2021 $ 467 2022 $ 404 2023 $ 372 2024 $ 354 2025 $ 266

NOTES PAYABLE, LONG-TERM DEBT_2

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Instrument [Line Items]
Schedule of Short-term Debt [Table Text Block]	Notes Payable Mar 31, Dec 31, In millions Commercial paper $ 250 $ 151 Notes payable to banks and other lenders 1 1,240 435 Total notes payable $ 1,490 $ 586 Period-end average interest rates 3.78 % 6.30 % 1. Includes $800 million drawn from uncommitted facilities in the first quarter of 2020.
Schedule of Long-term Debt Instruments [Table Text Block]	Long-Term Debt 2020 Average Rate Mar 31, 2019 Dec 31, In millions Promissory notes and debentures: Final maturity 2020 8.44 % $ 76 8.44 % $ 76 Final maturity 2021 8.95 % 173 8.95 % 174 Final maturity 2022 8.64 % 121 3.50 % 1,372 Final maturity 2023 7.64 % 325 7.64 % 325 Final maturity 2024 3.37 % 1,397 3.37 % 1,397 Final maturity 2025 5.26 % 662 5.26 % 662 Final maturity 2026 and thereafter 5.73 % 8,888 5.73 % 8,820 Other facilities: U.S. dollar loans 1.74 % 1,250 2.55 % 2,000 Foreign currency notes and loans, various rates and maturities 1.41 % 3,040 3.26 % 592 InterNotes®, varying maturities through 2050 3.44 % 702 3.44 % 928 Finance lease obligations 1 418 395 Unamortized debt discount and issuance costs (355) (331) Long-term debt due within one year 2 (384) (435) Long-term debt $ 16,313 $ 15,975 1. See Note 13 for additional information. 2. Presented net of current portion of unamortized debt issuance costs.
Schedule of Maturities of Long-term Debt [Table Text Block]	Maturities of Long-Term Debt for Next Five Years at Mar 31, 2020 In millions 2020 $ 359 2021 $ 491 2022 $ 225 2023 1 $ 1,693 2024 $ 1,504 2025 $ 780 1. Assumes the option to extend will be exercised for the $1.25 billion Dow Silicones Term Loan Facility.
Schedule of Line of Credit Facilities [Table Text Block]	The following table summarizes the Company's credit facilities: Committed and Available Credit Facilities at Mar 31, 2020 In millions Committed Credit Credit Available Maturity Date Interest Five Year Competitive Advance and Revolving Credit Facility $ 5,000 $ 5,000 October 2024 Floating rate Term Loan Facility 1 1,250 — September 2023 Floating rate European Securitization Facility 2 440 440 October 2020 Floating rate Bilateral Revolving Credit Facility 200 200 July 2020 Floating rate Bilateral Revolving Credit Facility 100 100 August 2020 Floating rate Bilateral Revolving Credit Facility 300 300 December 2020 Floating rate Bilateral Revolving Credit Facility 300 300 December 2021 Floating rate Bilateral Revolving Credit Facility 150 150 March 2022 Floating rate Bilateral Revolving Credit Facility 100 100 October 2024 Floating rate Bilateral Revolving Credit Facility 100 100 October 2024 Floating rate Bilateral Revolving Credit Facility 200 200 November 2024 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 250 250 March 2025 Floating rate Bilateral Revolving Credit Facility 275 275 March 2025 Floating rate Total committed and available credit facilities $ 8,765 $ 7,515 1. Assumes the option to extend the Term Loan Facility will be exercised. 2. Equivalent to €400 million.

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2020
Guarantor Obligations [Line Items]
Lease, Cost [Table Text Block]	The components of lease cost for operating and finance leases for the three months ended March 31, 2020 and 2019 were as follows: Lease Cost Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Operating lease cost $ 120 $ 125 Finance lease cost Amortization of right-of-use assets - finance $ 13 $ 6 Interest on lease liabilities - finance 6 6 Total finance lease cost $ 19 $ 12 Short-term lease cost 54 50 Variable lease cost 64 44 Sublease income (1) (1) Total lease cost $ 256 $ 230
Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block]	The following table provides supplemental cash flow information related to leases: Other Lease Information Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 126 $ 133 Operating cash flows for finance leases $ 6 $ 6 Financing cash flows for finance leases $ 8 $ 3
Schedule of Supplemental Balance Sheet Information Related to Leases [Table Text Block]	The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at March 31, 2020 and December 31, 2019: Lease Position Balance Sheet Classification Mar 31, 2020 Dec 31, 2019 In millions Right-of-use assets obtained in exchange for lease obligations: Operating leases 1 $ 38 $ 2,476 Finance leases $ 34 $ 89 Assets Operating lease assets Operating lease right-of-use assets $ 1,942 $ 2,072 Finance lease assets Property 526 486 Finance lease amortization Accumulated depreciation (179) (167) Total lease assets $ 2,289 $ 2,391 Liabilities Current Operating Operating lease liabilities - current $ 384 $ 421 Finance Long-term debt due within one year 49 32 Noncurrent Operating Operating lease liabilities - noncurrent 1,622 1,739 Finance Long-Term Debt 369 363 Total lease liabilities $ 2,424 $ 2,555 1. Includes $2.3 billion for the period ended December 31, 2019 related to the adoption of Topic 842.
Lease Terms and Discount Rates [Table Text Block]	Lease Term and Discount Rate Mar 31, 2020 Dec 31, 2019 Weighted-average remaining lease term Operating leases 8.0 years 8.0 years Finance leases 11.5 years 12.3 years Weighted-average discount rate Operating leases 4.10 % 4.09 % Finance leases 6.04 % 6.28 %
Maturities of Lease Liabilities [Table Text Block]	The following table provides the maturities of lease liabilities at March 31, 2020: Maturities of Lease Liabilities Mar 31, 2020 Operating Leases Finance Leases In millions 2020 $ 338 $ 56 2021 409 64 2022 349 57 2023 281 82 2024 218 29 2025 and thereafter 806 310 Total future undiscounted lease payments $ 2,401 $ 598 Less imputed interest 395 180 Total present value of lease liabilities $ 2,006 $ 418
Schedule of Guarantor Obligations [Table Text Block]	The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for guarantees: Guarantees Mar 31, 2020 Dec 31, 2019 In millions Final Maximum Recorded Final Maximum Recorded Guarantees 2023 $ 3,950 $ 10 2023 $ 3,952 $ 10
Residual Value Guarantees [Member]
Guarantor Obligations [Line Items]
Schedule of Guarantor Obligations [Table Text Block]	Lease Guarantees Mar 31, 2020 Dec 31, 2019 In millions Final Expiration Maximum Future Payments Recorded Liability Final Expiration Maximum Future Payments Recorded Liability Residual value guarantees 2028 $ 788 $ — 2028 $ 792 $ —

Equity (Tables)

Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2020 and 2019 were as follows: Accumulated Other Comprehensive Loss Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Unrealized Gains (Losses) on Investments Beginning balance $ 64 $ (51) Unrealized gains (losses) on investments (118) 86 Less: Tax (expense) benefit 25 (18) Net unrealized gains (losses) on investments (93) 68 (Gains) losses reclassified from AOCL to net income 1 (9) (1) Less: Tax expense (benefit) 2 2 — Net (gains) losses reclassified from AOCL to net income (7) (1) Other comprehensive income (loss), net of tax (100) 67 Ending balance $ (36) $ 16 Cumulative Translation Adjustment Beginning balance $ (1,135) $ (1,813) Gains (losses) on foreign currency translation (161) (12) Less: Tax (expense) benefit 12 (1) Net gains (losses) on foreign currency translation (149) (13) (Gains) losses reclassified from AOCL to net income 3 (14) (18) Other comprehensive income (loss), net of tax (163) (31) Ending balance $ (1,298) $ (1,844) Pension and Other Postretirement Benefits Beginning balance $ (8,781) $ (7,965) Amortization and recognition of net loss and prior service credits 4 185 166 Less: Tax expense (benefit) 2 (43) (25) Other comprehensive income (loss), net of tax 142 141 Ending balance $ (8,639) $ (7,824) Derivative Instruments Beginning balance $ (394) $ (56) Gains (losses) on derivative instruments (176) (95) Less: Tax (expense) benefit 10 27 Net gains (losses) on derivative instruments (166) (68) (Gains) losses reclassified from AOCL to net income 5 7 (7) Less: Tax expense (benefit) 2 (3) — Net (gains) losses reclassified from AOCL to net income 4 (7) Other comprehensive income (loss), net of tax (162) (75) Ending balance $ (556) $ (131) Total AOCL ending balance $ (10,529) $ (9,783) 1. Reclassified to "Net sales" and "Sundry income (expense) - net." 2. Reclassified to "Provision for income taxes on continuing operations." 3. Reclassified to "Sundry income (expense) - net." 4. These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note 16 for additional information. 5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

NONCONTROLLING INTERESTS Nonc_2

NONCONTROLLING INTERESTS Noncontrolling Interests (Tables)	3 Months Ended
	Mar. 31, 2020
Noncontrolling Interest [Abstract]
Noncontrolling Interests [Table Text Block]	The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2020 and 2019: Noncontrolling Interests Three Months Ended In millions Mar 31, 2020 Mar 31, 2019 Balance at beginning of period $ 553 $ 1,138 Net income attributable to noncontrolling interests - continuing operations 19 32 Net income attributable to noncontrolling interests - discontinued operations — 13 Distributions to noncontrolling interests 1 (1) (9) Cumulative translation adjustments (16) 7 Other — (1) Balance at end of period $ 555 $ 1,180 1. Includes amounts attributable to discontinued operations of $7 million for the three months ended March 31, 2019.

PENSION PLANS AND OTHER POSTR_2

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Tables)	3 Months Ended
	Mar. 31, 2020
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs [Table Text Block]	The following table provides the components of the Company's net periodic benefit cost for all significant plans: Net Periodic Benefit Cost for All Significant Plans Three Months Ended In millions Mar 31, Mar 31, Defined Benefit Pension Plans: Service cost $ 99 $ 112 Interest cost 192 241 Expected return on plan assets (414) (417) Amortization of prior service credit (5) (6) Amortization of net loss 192 132 Net periodic benefit cost $ 64 $ 62 Less: Discontinued operations — 21 Net periodic benefit cost - continuing operations $ 64 $ 41 Other Postretirement Benefit Plans: Service cost $ 2 $ 2 Interest cost 9 14 Amortization of net gain (2) (6) Net periodic benefit cost $ 9 $ 10

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Fair Value of Financial Instruments	The following table summarizes the fair value of financial instruments at March 31, 2020 and December 31, 2019: Fair Value of Financial Instruments Mar 31, 2020 Dec 31, 2019 In millions Cost Gain Loss Fair Value Cost Gain Loss Fair Value Cash equivalents: Held-to-maturity securities 1 $ 1,233 $ — $ — $ 1,233 $ 220 $ — $ — $ 220 Money market funds 573 — — 573 408 — — 408 Total cash equivalents $ 1,806 $ — $ — $ 1,806 $ 628 $ — $ — $ 628 Marketable securities $ 1 $ — $ — $ 1 $ 21 $ — $ — $ 21 Other investments: Debt securities: Government debt 2 $ 458 $ 37 $ (33) $ 462 $ 533 $ 33 $ (11) $ 555 Corporate bonds 877 43 (84) 836 944 80 (10) 1,014 Total debt securities $ 1,335 $ 80 $ (117) $ 1,298 $ 1,477 $ 113 $ (21) $ 1,569 Equity securities 3 8 1 (1) 8 10 6 (1) 15 Total other investments $ 1,343 $ 81 $ (118) $ 1,306 $ 1,487 $ 119 $ (22) $ 1,584 Total cash equivalents, marketable securities and other investments $ 3,150 $ 81 $ (118) $ 3,113 $ 2,136 $ 119 $ (22) $ 2,233 Long-term debt including debt due within one year 4 $ (16,697) $ 384 $ (1,326) $ (17,639) $ (16,410) $ 7 $ (2,258) $ (18,661) Derivatives relating to: Interest rates 5 $ — $ 194 $ (331) $ (137) $ — $ 8 $ (283) $ (275) Foreign currency — 53 (39) 14 — 101 (21) 80 Commodities 5 — 133 (286) (153) — 59 (115) (56) Total derivatives $ — $ 380 $ (656) $ (276) $ — $ 168 $ (419) $ (251) 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations. 3. Equity securities with a readily determinable fair value. 4. Cost includes fair value hedge adjustment gains of $68 million at March 31, 2020 and $1 million at December 31, 2019 on $2,790 million of debt at March 31, 2020 and $3,490 million of debt at December 31, 2019. 5. Presented net of cash collateral where master netting arrangements allow.
Investing Results	The following table provides the investing results from available-for-sale securities for the three months ended March 31, 2020 and 2019: Investing Results Three Months Ended In millions Mar 31, Mar 31, Proceeds from sales of available-for-sale securities $ 248 $ 159 Gross realized gains $ 16 $ 6 Gross realized losses $ (7) $ (5)
Contractual Maturities of Debt Securities	The following table summarizes the contractual maturities of the Company's investments in debt securities: Contractual Maturities of Debt Securities at Mar 31, 2020 1 Cost Fair Value In millions Within one year $ 12 $ 11 One to five years 363 340 Six to ten years 467 437 After ten years 493 510 Total $ 1,335 $ 1,298 1. Includes marketable securities with maturities of less than one year.
Fair Value and Gross Unrealized Losses of Investments Temporarily Impaired	The following table provides the fair value and gross unrealized losses of the Company’s investments in debt securities that were deemed to be temporarily impaired at March 31, 2020 and December 31, 2019, aggregated by investment category: Temporarily Impaired Debt Securities Less than 12 months 12 months or more Total Fair Unrealized Fair Unrealized Fair Value Unrealized Losses In millions Mar 31, 2020 Government debt 1 $ 109 $ (22) $ 10 $ (11) $ 119 $ (33) Corporate bonds 407 (66) 24 (18) 431 (84) Total temporarily impaired debt securities $ 516 $ (88) $ 34 $ (29) $ 550 $ (117) Dec 31, 2019 Government debt 1 $ 55 $ (3) $ 23 $ (8) $ 78 $ (11) Corporate bonds 79 (3) 52 (7) 131 (10) Total temporarily impaired debt securities $ 134 $ (6) $ 75 $ (15) $ 209 $ (21) 1. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities' obligations.
Equity Securities with and without Readily Determinable Fair Value	Investments in Equity Securities Mar 31, 2020 Dec 31, 2019 In millions Readily determinable fair value $ 8 $ 15 Not readily determinable fair value $ 190 $ 189
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts of the Company's derivative instruments presented on a net basis at March 31, 2020 and December 31, 2019 were as follows: Notional Amounts - Net Mar 31, 2020 Dec 31, 2019 In millions Derivatives designated as hedging instruments: Interest rate contracts $ 921 $ 922 Foreign currency contracts $ 3,472 $ 6,253 Derivatives not designated as hedging instruments: Interest rate contracts $ 105 $ 145 Foreign currency contracts $ 5,706 $ 5,567 The notional amounts of the Company's commodity derivatives presented on a net basis at March 31, 2020 and December 31, 2019 were as follows: Commodity Notionals - Net Mar 31, 2020 Dec 31, 2019 Notional Volume Unit Derivatives designated as hedging instruments: Hydrocarbon derivatives 20.0 6.1 million barrels of oil equivalent Derivatives not designated as hedging instruments: Hydrocarbon derivatives 0.4 0.1 million barrels of oil equivalent Power derivatives 80.5 87.5 thousands of megawatt hours
Schedule of Fair Values of Derivative Instruments	The following tables provide the fair value and balance sheet classification of derivative instruments at March 31, 2020 and December 31, 2019: Fair Value of Derivative Instruments Mar 31, 2020 In millions Balance Sheet Classification Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheets Asset derivatives Derivatives designated as hedging instruments: Interest rate contracts Other current assets $ 192 $ (156) $ 36 Foreign currency contracts Other current assets 109 (80) 29 Commodity contracts Other current assets 82 (32) 50 Commodity contracts Deferred charges and other assets 67 (3) 64 Total $ 450 $ (271) $ 179 Derivatives not designated as hedging instruments: Interest rate contracts Deferred charges and other assets $ 158 $ — $ 158 Foreign currency contracts Other current assets 65 (41) 24 Commodity contracts Other current assets 22 (4) 18 Commodity contracts Deferred charges and other assets 1 — 1 Total $ 246 $ (45) $ 201 Total asset derivatives $ 696 $ (316) $ 380 Liability derivatives Derivatives designated as hedging instruments: Interest rate contracts Accrued and other current liabilities $ 156 $ (156) $ — Foreign currency contracts Accrued and other current liabilities 88 (80) 8 Commodity contracts Accrued and other current liabilities 152 (32) 120 Commodity contracts Other noncurrent obligations 148 (3) 145 Total $ 544 $ (271) $ 273 Derivatives not designated as hedging instruments: Interest rate contracts Other noncurrent obligations $ 331 $ — $ 331 Foreign currency contracts Accrued and other current liabilities 71 (40) 31 Commodity contracts Accrued and other current liabilities 24 (4) 20 Commodity contracts Other noncurrent obligations 1 — 1 Total $ 427 $ (44) $ 383 Total liability derivatives $ 971 $ (315) $ 656 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Fair Value of Derivative Instruments Dec 31, 2019 In millions Balance Sheet Classification Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheets Asset derivatives Derivatives designated as hedging instruments: Interest rate contracts Other current assets $ 21 $ (13) $ 8 Foreign currency contracts Other current assets 105 (36) 69 Commodity contracts Other current assets 44 (25) 19 Commodity contracts Deferred charges and other assets 28 (3) 25 Total $ 198 $ (77) $ 121 Derivatives not designated as hedging instruments: Interest rate contracts Other current assets $ 14 $ (14) $ — Foreign currency contracts Other current assets 44 (12) 32 Commodity contracts Other current assets 18 (3) 15 Total $ 76 $ (29) $ 47 Total asset derivatives $ 274 $ (106) $ 168 Liability derivatives Derivatives designated as hedging instruments: Interest rate contracts Accrued and other current liabilities $ 23 $ (13) $ 10 Interest rate contracts Other noncurrent obligations 1 — 1 Foreign currency contracts Accrued and other current liabilities 46 (36) 10 Commodity contracts Accrued and other current liabilities 95 (29) 66 Commodity contracts Other noncurrent obligations 38 (4) 34 Total $ 203 $ (82) $ 121 Derivatives not designated as hedging instruments: Interest rate contracts Accrued and other current liabilities $ 136 $ (14) $ 122 Interest rate contracts Other noncurrent obligations 150 — 150 Foreign currency contracts Accrued and other current liabilities 23 (12) 11 Commodity contracts Accrued and other current liabilities 17 (3) 14 Commodity contracts Other noncurrent obligations 1 — 1 Total $ 327 $ (29) $ 298 Total liability derivatives $ 530 $ (111) $ 419
Derivative Instruments, Gain (Loss)	Effect of Derivative Instruments Amount of gain (loss) recognized in OCI 1 Amount of gain (loss) recognized in income 2 Income Statement Classification Three months ended Three months ended In millions Mar 31, 2020 Mar 31, 2019 Mar 31, 2020 Mar 31, 2019 Derivatives designated as hedging Fair value hedges: Interest rate contracts $ — $ — $ 24 $ — Interest expense and amortization of debt discount 3 Excluded components 4 3 — — — Interest expense and amortization Cash flow hedges: Interest rate contracts — (106) — — Interest expense and amortization Foreign currency contracts 8 7 4 8 Cost of sales Foreign currency contracts — 1 — — Sundry income (expense) - net Commodity contracts (87) 55 (11) — Cost of sales Net foreign investment hedges: Foreign currency contracts 22 30 — — Excluded components 4 22 86 14 25 Sundry income (expense) - net Total derivatives designated as hedging $ (32) $ 73 $ 31 $ 33 Derivatives not designated as hedging Interest rate contracts $ — $ — $ (6) $ — Interest expense and amortization Foreign currency contracts — — (19) (32) Sundry income (expense) - net Commodity contracts — — 11 (12) Cost of sales Total derivatives not designated as $ — $ — $ (14) $ (44) Total derivatives $ (32) $ 73 $ 17 $ (11) 1. OCI is defined as other comprehensive income (loss). 2. Pretax amounts. 3. Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item. 4. The excluded components are related to the time value of the derivatives designated as hedges.
Schedule of Hedging Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized Over Next Fiscal Year	The following table provides the net after-tax amounts expected to be reclassified from AOCL to income within the next 12 months: Expected Reclassifications from AOCL within the next 12 months Mar 31, 2020 In millions Cash flow hedges: Interest rate contracts $ 1 Commodity contracts $ (32) Foreign currency contracts $ 9 Net foreign investment hedges: Excluded components $ 10

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis: Basis of Fair Value Measurements on a Recurring Basis Mar 31, 2020 Dec 31, 2019 Quoted Prices in Active Markets for Identical Items Significant Other Observable Inputs Total Quoted Prices in Active Markets for Identical Items Significant Other Observable Inputs Total In millions Assets at fair value Cash equivalents Held-to-maturity securities 1 $ — $ 1,233 $ 1,233 $ — $ 220 $ 220 Money market funds — 573 573 — 408 408 Marketable securities — 1 1 — 21 21 Equity securities 2 8 — 8 15 — 15 Debt securities: 2 Government debt 3 — 462 462 — 555 555 Corporate bonds 20 816 836 22 992 1,014 Derivatives relating to: 4 Interest rates — 350 350 — 35 35 Foreign currency — 174 174 — 149 149 Commodities 31 141 172 23 67 90 Total assets at fair value $ 59 $ 3,750 $ 3,809 $ 60 $ 2,447 $ 2,507 Liabilities at fair value Long-term debt including debt due within one year 5 $ — $ 17,639 $ 17,639 $ — $ 18,661 $ 18,661 Derivatives relating to: 4 Interest rates — 487 487 — 310 310 Foreign currency — 159 159 — 69 69 Commodities 18 307 325 14 137 151 Total liabilities at fair value $ 18 $ 18,592 $ 18,610 $ 14 $ 19,177 $ 19,191 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets. 3. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations. 4. See Note 18 for the classification of derivatives in the consolidated balance sheets. 5. See Note 18 for information on fair value measurements of long-term debt.

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Schedule of Related Party Transactions [Table Text Block]	The following table presents revenue earned and expenses incurred related to transactions with Historical DuPont and its affiliates: Sales to Historical DuPont and its Affiliates Three months ended In millions Mar 31, Net sales $ 12 Cost of sales $ 9

SEGMENTS AND GEOGRAPHIC REGIO_2

SEGMENTS AND GEOGRAPHIC REGIONS (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Segment Information Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Three months ended Mar 31, 2020 Net sales $ 4,609 $ 3,045 $ 2,065 $ 51 $ 9,770 Equity in earnings (losses) of nonconsolidated affiliates 5 (76) 1 (19) (89) Dow Inc. Operating EBIT 1 580 175 162 (74) 843 Three months ended Mar 31, 2019 Net sales $ 5,138 $ 3,480 $ 2,282 $ 69 $ 10,969 Pro forma net sales 5,138 3,489 2,320 69 11,016 Equity in earnings (losses) of nonconsolidated affiliates 38 (48) — (4) (14) Dow Inc. pro forma Operating EBIT 2 690 277 271 (95) 1,143 1. Operating EBIT for TDCC for the three months ended March 31, 2020 is substantially the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Income from continuing operations, net of tax" to Operating EBIT is provided on the following page. 2. Pro forma Operating EBIT for TDCC for the three months ended March 31, 2019 is the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Income from continuing operations, net of tax" to pro forma Operating EBIT is provided on the following page.
Reconciliation of income from continuing operations, net of tax to Operating EBIT [Table Text Block]	Reconciliation of "Income from continuing operations, net of tax" to Operating EBIT Three Months Ended In millions Mar 31, 2020 Income from continuing operations, net of tax $ 258 + Provision for income taxes on continuing operations 138 Income from continuing operations before income taxes $ 396 - Interest income 15 + Interest expense and amortization of debt discount 215 - Significant items (247) Operating EBIT $ 843 Reconciliation of "Income from continuing operations, net of tax" to Pro Forma Operating EBIT Three Months Ended In millions Mar 31, 2019 Income from continuing operations, net of tax $ 156 + Provision for income taxes on continuing operations 141 Income from continuing operations before income taxes $ 297 - Interest income 18 + Interest expense and amortization of debt discount 241 + Pro forma adjustments 1 65 - Significant items (558) Pro forma Operating EBIT $ 1,143
Schedule of significant items [Table Text Block]	The following tables summarize the pretax impact of significant items by segment that are excluded from Operating EBIT and pro forma Operating EBIT: Significant Items by Segment Three Months Ended Mar 31, 2020 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Mat. & Coatings Corp. Total In millions Integration and separation costs 1 $ — $ — $ — $ (65) $ (65) Restructuring and asset related charges - net 2 (6) — — (90) (96) Loss on early extinguishment of debt 3 — — — (86) (86) Total $ (6) $ — $ — $ (241) $ (247) 1. Costs related to business separation activities. 2. Includes Board approved restructuring plans and asset related charges, which include other asset impairments. See Note 5 for additional information. 3. The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 11 for additional information. Significant Items by Segment Three Months Ended Mar 31, 2019 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Mat. & Coatings Corp. Total In millions Integration and separation costs 1 $ — $ — $ — $ (402) $ (402) Restructuring and asset related charges - net 2 (13) — — (143) (156) Total $ (13) $ — $ — $ (545) $ (558) 1. Costs related to business separation activities. Excludes one-time transaction costs directly attributable to the Merger.

SEPARATION FROM DOWDUPONT Sep_3

SEPARATION FROM DOWDUPONT Separation from DowDuPont (Details) - USD ($) $ / shares in Units, $ in Millions	Apr. 01, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Common Stock, Par or Stated Value Per Share		$ 0.01		$ 0.01
Common Stock, Shares, Issued		753,534,116		751,228,644
Settlements and transfers related to separation from DowDuPont Inc.		$ 0	$ 36
Dow Inc. [Member]
Common Stock, Par or Stated Value Per Share	$ 0.01
Common Stock, Shares, Issued	748,800,000
Proceeds from Contributions from Parent	$ 2,024
DowDuPont [Member]
Common Stock, Par or Stated Value Per Share	$ 0.01
The Dow Chemical Company [Domain]
Common Stock, Par or Stated Value Per Share		$ 0.01		$ 0.01
Common Stock, Shares, Issued		100		100
Settlements and transfers related to separation from DowDuPont Inc.		$ 0	(36)
Retained Earnings [Member]
Settlements and transfers related to separation from DowDuPont Inc.		0	35	$ 14,806
Retained Earnings [Member] | The Dow Chemical Company [Domain]
Settlements and transfers related to separation from DowDuPont Inc.		$ 0	$ 35	$ 16,009

SEPARATION FROM DOWDUPONT Disco

SEPARATION FROM DOWDUPONT Discontinued Operations - Income Statement (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net sales	$ 9,770	$ 10,969
Cost of sales	8,230	9,142
Selling, general and administrative expenses	334	448
Amortization of intangibles	100	116
Restructuring and asset related charges - net	96	156
Equity in earnings of nonconsolidated affiliates	(89)	(14)
Sundry income (expense) - net	(81)	69
Interest income	15	18
Interest expense and amortization of debt discount	215	241
Provision for income taxes	138	141
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	$ 0	445
Discontinued Operations [Member]
Net sales		2,953
Cost of sales		1,804
Research and Development Expense		175
Selling, general and administrative expenses		262
Amortization of intangibles		61
Restructuring and asset related charges - net		78
Equity in earnings of nonconsolidated affiliates		28
Sundry income (expense) - net		(18)
Interest income		3
Interest expense and amortization of debt discount		7
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax		579
Provision for income taxes		134
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent		$ 445

SEPARATION FROM DOWDUPONT Sep_4

SEPARATION FROM DOWDUPONT Separation, Distribution and Tax Agreements (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Apr. 01, 2019
Cash receipt related to divestiture	$ 6
Integration and separation costs	65	$ 452
Discontinued Operations [Member]
Cash receipt related to divestiture	3
Continuing Operations [Member]
Cash receipt related to divestiture	3
Other Current Assets [Member]
Indemnification Asset	51		$ 58
Other noncurrent assets
Indemnification Asset	32		52
Accrued and Other Current Liabilities [Member]
Indemnification liability	319		352
Deferred cash contribution	130		130
Other Noncurrent Obligations [Member]
Indemnification liability	105		96
Deferred cash contribution	270		$ 270	$ 400
The Dow Chemical Company [Domain]
Integration and separation costs	$ 65	$ 452

REVENUE (Details)

REVENUE (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Revenue from External Customer [Line Items]
Revenue, Percentage from Products and Service Transferred to Customers	99.00%	99.00%
Revenue, Remaining Performance Obligation, Amount	$ 829		$ 826
Revenues	9,770	$ 10,969
Contract with Customer, Liability, Revenue Recognized	35	55
Contract with Customer, Asset, Reclassified to Receivable	10	15
Accounts and notes receivable - Trade	4,841		4,844
Contract assets - current 1	22		41
Contract assets - noncurrent 2	17		4
Contract liabilities - current 3	196		193
Contract liabilities - noncurrent 4	$ 1,602		$ 1,607
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-04-01
Revenue from External Customer [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	21 years
U.S. & Canada
Revenue from External Customer [Line Items]
Revenues	$ 3,550	3,933
EMEAI 1
Revenue from External Customer [Line Items]
Revenues	3,411	3,882
Asia Pacific
Revenue from External Customer [Line Items]
Revenues	1,845	2,101
Latin America
Revenue from External Customer [Line Items]
Revenues	964	1,053
Packaging & Specialty Plastics [Member]
Revenue from External Customer [Line Items]
Revenues	4,609	5,138
Packaging & Specialty Plastics [Member] | Hydrocarbons & Energy [Member]
Revenue from External Customer [Line Items]
Revenues	1,219	1,404
Packaging & Specialty Plastics [Member] | Packaging and Specialty Plastics [Member]
Revenue from External Customer [Line Items]
Revenues	3,390	3,734
Industrial Intermediates & Infrastructure [Member]
Revenue from External Customer [Line Items]
Revenues	3,045	3,480
Industrial Intermediates & Infrastructure [Member] | Industrial Solutions [Member]
Revenue from External Customer [Line Items]
Revenues	1,054	1,127
Industrial Intermediates & Infrastructure [Member] | Polyurethanes & CAV [Member]
Revenue from External Customer [Line Items]
Revenues	1,988	2,350
Industrial Intermediates & Infrastructure [Member] | Other [Member]
Revenue from External Customer [Line Items]
Revenues	3	3
Performance Materials & Coatings [Member]
Revenue from External Customer [Line Items]
Revenues	2,065	2,282
Performance Materials & Coatings [Member] | Coatings and Performance Monomers [Member]
Revenue from External Customer [Line Items]
Revenues	828	902
Performance Materials & Coatings [Member] | Consumer Solutions [Member]
Revenue from External Customer [Line Items]
Revenues	1,237	1,380
Corporate Segment [Member]
Revenue from External Customer [Line Items]
Revenues	$ 51	$ 69

Restructuring and Related Act_2

Restructuring and Related Activities (DowDupont Cost Synergy Program) (Details) - USD ($) $ in Millions	3 Months Ended					31 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Mar. 31, 2020	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	$ 96				$ 156
The Dow Chemical Company [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	96				156
DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	118	$ 71	$ 127	$ 159	202	$ 118	$ 217
Restructuring and asset related charges - net	90	33	56	59	144	965
Restructuring Reserve, Settled without Cash		33	5	29	76
Payments for Restructuring	43	56	83	73	83
DowDuPont Cost Synergy Program [Member] | Accrued and Other Current Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	104	52				104
DowDuPont Cost Synergy Program [Member] | Other Noncurrent Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	14	19				14
DowDuPont Cost Synergy Program [Member] | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					1
DowDuPont Cost Synergy Program [Member] | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	90	26	50	37	143
DowDuPont Cost Synergy Program [Member] | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		5	1	22
DowDuPont Cost Synergy Program [Member] | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		2	5
Employee Severance [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	102	54	106	137	183	102	210
Restructuring and asset related charges - net	90	0	46	25	52	657
Restructuring Reserve, Settled without Cash		0	0	0	0
Payments for Restructuring	42	52	77	71	79
Employee Severance [Member] | DowDuPont Cost Synergy Program [Member] | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					0
Employee Severance [Member] | DowDuPont Cost Synergy Program [Member] | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	90	0	46	25	52
Employee Severance [Member] | DowDuPont Cost Synergy Program [Member] | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		0	0	0
Employee Severance [Member] | DowDuPont Cost Synergy Program [Member] | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		0	0
Asset write-downs and write-offs [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	0	0	0	0	0	0	0
Restructuring and asset related charges - net	0	33	5	29	76	263
Restructuring Reserve, Settled without Cash		33	5	29	76
Payments for Restructuring	0	0	0	0	0
Asset write-downs and write-offs [Member] | DowDuPont Cost Synergy Program [Member] | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					0
Asset write-downs and write-offs [Member] | DowDuPont Cost Synergy Program [Member] | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	0	26	4	7	76
Asset write-downs and write-offs [Member] | DowDuPont Cost Synergy Program [Member] | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		5	1	22
Asset write-downs and write-offs [Member] | DowDuPont Cost Synergy Program [Member] | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		2	0
Costs Associated with Exit and Disposal Activities [Member] | DowDuPont Cost Synergy Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	16	17	21	22	19	16	$ 7
Restructuring and asset related charges - net	0	0	5	5	16	$ 45
Restructuring Reserve, Settled without Cash		0	0	0	0
Payments for Restructuring	1	4	6	2	4
Costs Associated with Exit and Disposal Activities [Member] | DowDuPont Cost Synergy Program [Member] | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					1
Costs Associated with Exit and Disposal Activities [Member] | DowDuPont Cost Synergy Program [Member] | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	$ 0	0	0	5	$ 15
Costs Associated with Exit and Disposal Activities [Member] | DowDuPont Cost Synergy Program [Member] | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		0	0	$ 0
Costs Associated with Exit and Disposal Activities [Member] | DowDuPont Cost Synergy Program [Member] | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		$ 0	$ 5

Restructuring and Related Act_3

Restructuring and Related Activities (Asset Related Charges) (Details) - Manufacturing Facility [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restructuring and Related Activities [Abstract]
Asset Impairment Charges		$ 12
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges		$ 12
Packaging & Specialty Plastics [Member]
Restructuring and Related Activities [Abstract]
Asset Impairment Charges	$ 6
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges	$ 6

Summary of Sundry Income (Expen

Summary of Sundry Income (Expense) - Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Sundry income (expense) - net	$ (81)	$ 69
Gain (Loss) on Extinguishment of Debt	(86)
Corporate Segment [Member]
Gain (Loss) on Extinguishment of Debt	(86)
The Dow Chemical Company [Domain]
Sundry income (expense) - net	$ (82)	$ 69

Company-Owned Life Insurance (D

Company-Owned Life Insurance (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Life Insurance, Corporate or Bank Owned, Amount	$ 541	$ 735
Gross Life Insurance, Corporate or Bank Owned, Amount	828	820
COLI Monetization [Member]
Other Short-term Borrowings	$ 287	$ 85

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Apr. 01, 2019
Income from continuing operations, net of tax	$ 258	$ 156
Net income attributable to noncontrolling interests - continuing operations	19	32
Net income attributable to participating securities - continuing operations 1	2	0
Income from continuing operations attributable to common stockholders	237	124
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Net income attributable to noncontrolling interests - discontinued operations	0	13
Income from discontinued operations attributable to common stockholders	0	432
Net income attributable to common stockholders	$ 237	$ 556
Earnings per common share from continuing operations - basic	$ 0.32	$ 0.16
Earnings per common share from discontinued operations - basic	0	0.58
Earnings per common share - basic	0.32	0.74
Earnings per common share from continuing operations - diluted	0.32	0.16
Earnings per common share from discontinued operations - diluted	0	0.58
Earnings per common share - diluted	$ 0.32	$ 0.74
Weighted-average common shares outstanding - basic	740.2	747.2
Dilutive effect of equity compensation plans	1.8	0
Weighted-average common shares outstanding - diluted	742	747.2
Stock options and restricted stock units excluded from EPS calculations	15.5	0
Employee Stock Ownership Plan (ESOP), Shares in ESOP			4.6
DowDuPont [Member]
Common Stock, Shares, Outstanding			2,246.3

NONCONSOLIDATED AFFILIATES (Det

NONCONSOLIDATED AFFILIATES (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	$ 1,235	$ 1,404
Equity Method Investment, Liability, Noncurrent	(317)	(80)
Equity Method Investment, Net of Investment Liabilities	918	1,324
Accounts and notes receivable - Other	2,770	2,711
The Kuwait Styrene Company K.S.C.C. [Member]
Schedule of Equity Method Investments [Line Items]
Proceeds from Equity Method Investment, Distribution	42
EQUATE Petrochemical Company Ksc and The Kuwait Olefins Company K.S.C.C. [Member]
Schedule of Equity Method Investments [Line Items]
Accounts and notes receivable - Other	276
EQUATE Petrochemical Company Ksc [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Liability, Noncurrent	225	80
Sadara Chemical Company [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Liability, Noncurrent	$ 92	$ 0

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Goodwill (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill	$ 8,780	$ 8,796
Goodwill, Foreign Currency Translation Gain (Loss)	(16)
Packaging & Specialty Plastics [Member]
Goodwill [Line Items]
Goodwill	5,108	5,109
Goodwill, Foreign Currency Translation Gain (Loss)	(1)
Industrial Intermediates & Infrastructure [Member]
Goodwill [Line Items]
Goodwill	1,099	1,100
Goodwill, Foreign Currency Translation Gain (Loss)	(1)
Performance Materials & Coatings [Member]
Goodwill [Line Items]
Goodwill	2,573	$ 2,587
Goodwill, Foreign Currency Translation Gain (Loss)	$ (14)

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Other Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 7,630	$ 7,642
Finite-Lived Intangible Assets, Accumulated Amortization	3,994	3,886
Finite-Lived Intangible Assets, Net	3,636	3,756
Intangible Assets, Gross (Excluding Goodwill)	7,630	7,645
Other intangible assets	3,636	3,759
Developed technology
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	2,636	2,634
Finite-Lived Intangible Assets, Accumulated Amortization	1,518	1,467
Finite-Lived Intangible Assets, Net	1,118	1,167
Software
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,458	1,449
Finite-Lived Intangible Assets, Accumulated Amortization	915	893
Finite-Lived Intangible Assets, Net	543	556
Trademarks/tradenames
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	352	352
Finite-Lived Intangible Assets, Accumulated Amortization	342	342
Finite-Lived Intangible Assets, Net	10	10
Customer-related
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	3,184	3,207
Finite-Lived Intangible Assets, Accumulated Amortization	1,219	1,184
Finite-Lived Intangible Assets, Net	1,965	2,023
In-process research and development
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)	$ 0	$ 3

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Amortization Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 100	$ 116
Other intangible assets, excluding software
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	100	116
Software
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 24	$ 24

GOODWILL AND OTHER INTANGIBLE_6

GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of Future Amortization Expense (Details) $ in Millions	Mar. 31, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2020	$ 491
2021	467
2022	404
2023	372
2024	354
2025	$ 266

NOTES PAYABLE, LONG-TERM DEBT_3

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Notes Payable (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Short-term Debt [Line Items]
Short-term Debt	$ 1,490	$ 586
Period-end average interest rates	3.78%	6.30%
Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term Debt	$ 250	$ 151
Notes Payable to Banks [Member]
Short-term Debt [Line Items]
Short-term Debt	1,240	$ 435
Notes Payable to Banks [Member] | Uncommitted Credit Facility [Member]
Short-term Debt [Line Items]
Short-term Debt	$ 800

NOTES PAYABLE, LONG-TERM DEBT_4

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Long-Term Debt (Details) € in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Mar. 31, 2020EUR (€)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Debt Instrument [Line Items]
Finance lease obligations 1				$ 418
Unamortized debt discount and issuance costs				(355)	$ (331)
Long-term debt due within one year 2				(384)	(435)
Long-term debt				16,313	15,975
Long-term Debt, Maturities, Repayments of Principal, 2020				359
Long-term Debt, Maturities, Repayments of Principal, 2021				491
Long-term Debt, Maturities, Repayments of Principal, 2022				225
Long-term Debt, Maturities, Repayments of Principal, 2023				1,693
Long-term Debt, Maturities, Repayments of Principal, 2024				1,504
Long-term Debt, Maturities, Repayments of Principal, 2025				780
Line of Credit Facility, Maximum Borrowing Capacity				8,765
Gain (Loss) on Extinguishment of Debt	$ (86)
Short-term Debt				1,490	586
Notes Payable to Banks [Member]
Debt Instrument [Line Items]
Short-term Debt				1,240	$ 435
Uncommitted Credit Facility [Member] | Notes Payable to Banks [Member]
Debt Instrument [Line Items]
Short-term Debt				800
Term Loan Facility, Due September 2023 | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity				$ 1,250
Repayments of Debt	750
Euros Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount | €			€ 2,250
Debt Instrument, Interest Rate, Stated Percentage			1.00%	1.00%
0.50 Percent Notes Due 2027 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount | €			€ 1,000
Debt Instrument, Interest Rate, Stated Percentage			0.50%	0.50%
1.125 Percent Notes Due 2032 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount | €			€ 750
Debt Instrument, Interest Rate, Stated Percentage			1.125%	1.125%
1.875 Percent Notes Due 2040 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount | €			€ 500
Debt Instrument, Interest Rate, Stated Percentage			1.875%	1.875%
3.0 Percent Notes Due 2022 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			3.00%	3.00%
Repayments of Notes Payable	1,250
3.0 Percent Notes Due 2022 [Member] | Sundry Income (Expense), Net [Member]
Debt Instrument [Line Items]
Gain (Loss) on Extinguishment of Debt	85
InterNotes redeemed [Member]
Debt Instrument [Line Items]
Repayments of Notes Payable	62	$ 72
Notes Issued	37
InterNotes redeemed, Various maturities [Member]
Debt Instrument [Line Items]
Repayments of Notes Payable	200
InterNotes redeemed, Various maturities [Member] | Sundry Income (Expense), Net [Member]
Debt Instrument [Line Items]
Gain (Loss) on Extinguishment of Debt	$ 1
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Current Year [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			8.44%	8.44%	8.44%
Long-term Debt, Gross				$ 76	$ 76
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year One [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			8.95%	8.95%	8.95%
Long-term Debt, Gross				$ 173	$ 174
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Two [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			8.64%	8.64%	3.50%
Long-term Debt, Gross				$ 121	$ 1,372
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Three [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			7.64%	7.64%	7.64%
Long-term Debt, Gross				$ 325	$ 325
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Four [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			3.37%	3.37%	3.37%
Long-term Debt, Gross				$ 1,397	$ 1,397
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Five [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			5.26%	5.26%	5.26%
Long-term Debt, Gross				$ 662	$ 662
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Six and Thereafter [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			5.73%	5.73%	5.73%
Long-term Debt, Gross				$ 8,888	$ 8,820
Loans Payable [Member] | U.S. Dollar Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			1.74%	1.74%	2.55%
Long-term Debt, Gross				$ 1,250	$ 2,000
Loans Payable [Member] | Foreign Currency Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			1.41%	1.41%	3.26%
Long-term Debt, Gross				$ 3,040	$ 592
Medium-term Notes [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time			3.44%	3.44%	3.44%
Long-term Debt, Gross				$ 702	$ 928
Finance Leases [Member]
Debt Instrument [Line Items]
Finance lease obligations 1				$ 418	$ 395

NOTES PAYABLE, LONG-TERM DEBT_5

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Committed and Available Credit Facilities (Details) - Mar. 31, 2020 € in Millions, $ in Millions	EUR (€)	USD ($)
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 8,765
Line of Credit Facility, Remaining Borrowing Capacity		7,515
Five Year Competitive Advance and Revolving Credit Facility [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		5,000
Line of Credit Facility, Remaining Borrowing Capacity		5,000
Term Loan Facility, Due September 2023 | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		1,250
Line of Credit Facility, Remaining Borrowing Capacity		0
European Securitization Facility, Due October 2020 [Member] | Secured Debt [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	€ 400	440
Line of Credit Facility, Remaining Borrowing Capacity		440
Bilateral Revolving Credit Facility, Due July 2020 [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		200
Line of Credit Facility, Remaining Borrowing Capacity		200
Bilateral Revolving Credit Facility, Due August 2020 [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		100
Line of Credit Facility, Remaining Borrowing Capacity		100
Bilateral Revolving Credit Facility, Due December 2020 | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		300
Line of Credit Facility, Remaining Borrowing Capacity		300
Bilateral Revolving Credit Facility, Due December 2021 | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		300
Line of Credit Facility, Remaining Borrowing Capacity		300
Bilateral Revolving Credit Facility, Due March 2022 | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		150
Line of Credit Facility, Remaining Borrowing Capacity		150
Bilateral Revolving Credit Facility, Due October 2024, Facility One | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		100
Line of Credit Facility, Remaining Borrowing Capacity		100
Bilateral Revolving Credit Facility, Due October 2024, Facility Two | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		100
Line of Credit Facility, Remaining Borrowing Capacity		100
Bilateral Revolving Credit Facility, Due November 2024 | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		200
Line of Credit Facility, Remaining Borrowing Capacity		200
Bilateral Revolving Credit Facility, Due March 2025, Facility One | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		100
Line of Credit Facility, Remaining Borrowing Capacity		100
Bilateral Revolving Credit Facility, Due March 2025, Facility Two | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		250
Line of Credit Facility, Remaining Borrowing Capacity		250
Bilateral Revolving Credit Facility, Due March 2025, Facility Three | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		275
Line of Credit Facility, Remaining Borrowing Capacity		$ 275

COMMITMENTS AND CONTINGENT LI_6

COMMITMENTS AND CONTINGENT LIABILITES (Dow Silicones Chapter 11 Related Matters) (Details) (Details) - Dow Silicones Corporation [Member] - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Jun. 01, 2016
Product Liability Contingency [Line Items]
Business Combination, Indemnification Assets, Percentage of Future Losses			50.00%
Indemnification Asset	$ 100	$ 100
Breast Implant and Other Products Liability Claims [Member]
Product Liability Contingency [Line Items]
Product Liability Contingency, Payments Incurred To Date	1,762
Product Liability Contingency, Unexpended Balance	70
Loss Contingency Accrual, Product Liability, Net	165	165
Accrued and Other Current Liabilities [Member] | Breast Implant and Other Products Liability Claims [Member]
Product Liability Contingency [Line Items]
Loss Contingency Accrual, Product Liability, Net	45	20
Other Noncurrent Obligations [Member] | Breast Implant and Other Products Liability Claims [Member]
Product Liability Contingency [Line Items]
Loss Contingency Accrual, Product Liability, Net	$ 120	$ 145

COMMITMENTS AND CONTINGENT LI_7

COMMITMENTS AND CONTINGENT LIABILITIES Indemnifications with Corning (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019	Jun. 01, 2016
Other noncurrent assets
Loss Contingencies [Line Items]
Indemnification Asset	$ 32	$ 52
Other Current Assets [Member]
Loss Contingencies [Line Items]
Indemnification Asset	51	58
Dow Silicones Corporation [Member]
Loss Contingencies [Line Items]
Business Combination, Indemnification Assets, Percentage of Future Losses			50.00%
Indemnification Asset	100	100
Dow Silicones Corporation [Member] | Other Current Assets [Member] | Commercial Creditors Litigation [Member]
Loss Contingencies [Line Items]
Indemnification Asset	37	37
Environmental Issue [Member] | Dow Silicones Corporation [Member] | Other noncurrent assets
Loss Contingencies [Line Items]
Indemnification Asset	$ 63	$ 63

COMMITMENTS AND CONTINGENT LI_8

COMMITMENTS AND CONTINGENT LIABILITIES (Nova Patent Infringement Matter) (Details) - Dow V. Nova Chemicals Corporation Patent Infringement Matter [Member] $ in Millions, $ in Millions	Jul. 06, 2017USD ($)	Jun. 29, 2017USD ($)	Jun. 29, 2017CAD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Gain Contingencies [Line Items]
Litigation Settlement, Amount Awarded from Other Party		$ 495	$ 645
Proceeds from Legal Settlements	$ 501
Estimated Litigation Liability, Noncurrent				$ 341	$ 341

COMMITMENTS AND CONTINGENT LI_9

COMMITMENTS AND CONTINGENT LIABILITIES Nova Ethylene Asset Matter (Details) - Nova Ethylene Asset Matter [Member] $ in Millions, $ in Millions	Oct. 11, 2019USD ($)	Oct. 11, 2019CAD ($)	Sep. 18, 2019USD ($)	Sep. 18, 2019CAD ($)	Oct. 24, 2019CAD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Gain Contingencies [Line Items]
Estimated Litigation Liability, Noncurrent						$ 893	$ 893
Litigation Settlement, Amount Awarded from Other Party			$ 1,080	$ 1,430		$ 259
Litigation settlement, Amount Awarded from Other Party - Withholding Tax					$ 347
Proceeds from Legal Settlements	$ 800	$ 1,080

LEASES (Details)

LEASES (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Operating Lease, Expense	$ 120	$ 125
Finance Lease, Right-of-Use Asset, Amortization	13	6
Finance Lease, Interest Expense	6	6
Finance Lease, Cost	19	12
Short-term Lease, Cost	54	50
Variable Lease, Cost	64	44
Sublease Income	(1)	(1)
Lease, Cost	256	230
Operating Lease, Payments	126	133
Finance Lease, Interest Payment on Liability	6	6
Finance Lease, Principal Payments	8	$ 3
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	38		$ 2,476
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	34		89
Operating Lease, Right-of-Use Asset	1,942		2,072
Property, Plant and Equipment, Gross	54,942		54,910
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	(34,136)		(33,914)
Total Lease Assets	2,289		2,391
Operating Lease, Liability, Current	384		421
Finance Lease, Liability, Current	49		32
Operating Lease, Liability, Noncurrent	1,622		1,739
Finance Lease, Liability, Noncurrent	369		363
Total Lease Liabilities	$ 2,424		$ 2,555
Operating Lease, Weighted Average Remaining Lease Term	8 years		8 years
Finance Lease, Weighted Average Remaining Lease Term	11 years 6 months		12 years 3 months 18 days
Operating Lease, Weighted Average Discount Rate, Percent	4.10%		4.09%
Finance Lease, Weighted Average Discount Rate, Percent	6.04%		6.28%
Lessee, Operating Lease, Liability, Payments, Due 2020	$ 338
Finance Lease, Liability, Payments, Due 2020	56
Lessee, Operating Lease, Liability, Payments, Due 2021	409
Finance Lease, Liability, Payments, Due 2021	64
Lessee, Operating Lease, Liability, Payments, Due 2022	349
Finance Lease, Liability, Payments, Due 2022	57
Lessee, Operating Lease, Liability, Payments, Due 2023	281
Finance Lease, Liability, Payments, Due 2023	82
Lessee, Operating Lease, Liability, Payments, Due 2024	218
Finance Lease, Liability, Payments, Due 2024	29
Lessee, Operating Lease, Liability, Payments, Due 2025 and thereafter	806
Finance Lease, Liability, Payments, Due 2025 and thereafter	310
Lessee, Operating Lease, Liability, Payments, Due	2,401
Finance Lease, Liability, Payment, Due	598
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	395
Finance Lease, Liability, Undiscounted Excess Amount	180
Operating Lease, Liability	2,006
Finance lease obligations 1	418
Lessor, Operating Lease, Lease Not yet Commenced, Assumption and Judgment, Value of Underlying Asset, Amount	$ 65
Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract	20 years
Residual Value Guarantees [Member]
Guarantor Obligations, Maximum Exposure, Undiscounted	$ 788		$ 792
Guarantor Obligations, Current Carrying Value	0		0
Finance Leases [Member]
Property, Plant and Equipment, Gross	526		486
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ (179)		(167)
Accounting Standards Update 2016-02 [Member]
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability			$ 2,300

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	$ (10,529)	$ (9,783)	$ (10,246)
Other Comprehensive Income (Loss), Net of Tax	(283)	102
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(36)	16	64	$ (51)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(118)	86
Other Comprehensive Income (Loss), Tax	25	(18)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(93)	68
Other Comprehensive Income (Loss), Net of Tax	(100)	67
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(9)	(1)
Reclassification from AOCI, Current Period, Tax	2	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	(7)	(1)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(1,298)	(1,844)	(1,135)	(1,813)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(161)	(12)
Other Comprehensive Income (Loss), Tax	12	(1)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(149)	(13)
Other Comprehensive Income (Loss), Net of Tax	(163)	(31)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	(14)	(18)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(8,639)	(7,824)	(8,781)	(7,965)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	185	166
Reclassification from AOCI, Current Period, Tax	(43)	(25)
Other Comprehensive Income (Loss), Net of Tax	142	141
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(556)	(131)	$ (394)	$ (56)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(176)	(95)
Other Comprehensive Income (Loss), Tax	10	27
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(166)	(68)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	7	(7)
Reclassification from AOCI, Current Period, Tax	(3)	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	4	(7)
Other Comprehensive Income (Loss), Net of Tax	$ (162)	$ (75)

NONCONTROLLING INTERESTS Nonc_3

NONCONTROLLING INTERESTS Noncontrolling Interests (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Noncontrolling Interest [Line Items]
Balance at beginning of period	$ 553
Net income attributable to noncontrolling interests - continuing operations	(19)	$ (32)
Net income attributable to noncontrolling interests - discontinued operations	0	(13)
Balance at end of period	555	1,180
Noncontrolling Interest [Member]
Noncontrolling Interest [Line Items]
Balance at beginning of period	553	1,138
Net income attributable to noncontrolling interests - continuing operations	19	32
Net income attributable to noncontrolling interests - discontinued operations	0	13
Distributions to noncontrolling interests 1	(1)	(9)
Cumulative translation adjustments	16	(7)
Other	0	(1)
Balance at end of period	555	$ 1,180
Noncontrolling Interest [Member] | Discontinued Operations [Member]
Noncontrolling Interest [Line Items]
Distributions to noncontrolling interests 1	$ 7

PENSION PLANS AND OTHER POSTR_3

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Revenue, Percentage from Products and Service Transferred to Customers	99.00%	99.00%
Pension Plan [Member]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	$ 99	$ 112
Interest cost	192	241
Expected return on plan assets	(414)	(417)
Amortization of prior service credit	(5)	(6)
Amortization of net (gain) loss	192	132
Net periodic benefit cost - including discontinued operations	64	62
Net periodic benefit cost	64	41
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year	290
Defined Benefit Plan, Plan Assets, Contributions by Employer	63
Pension Plan [Member] | Discontinued Operations [Member]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Net periodic benefit cost	0	21
Other Postretirement Benefits [Member]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost	2	2
Interest cost	9	14
Amortization of net (gain) loss	(2)	(6)
Net periodic benefit cost - including discontinued operations	$ 9	$ 10

Fair Value of Financial Instrum

Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents, at Carrying Value	$ 1,806	$ 628
Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax	0	0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Fair Value	1,806	628
Available-for-sale Debt Securities, Amortized Cost Basis, Current	1	21
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Current, before Tax	0	0
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Current, before Tax	0	0
Debt Securities, Available-for-sale, Current	1	21
Debt Securities, Available-for-sale, Amortized Cost	1,335	1,477
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	80	113
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(117)	(21)
Debt Securities, Available-for-sale	1,298	1,569
Equity Securities, Amortized Cost Basis	8	10
Equity Securities, Accumulated Gross Unrealized Gain, Before Tax	1	6
Equity Securities, Accumulated Gross Unrealized Loss, Before Tax	(1)	(1)
Equity Securities, Fair Value	8	15
Other Investments and Securities, at Cost	1,343	1,487
Other Investments and Securities, Accumulated Gross Unrealized Gain, Before Tax	81	119
Other Investments and Securities, Accumulated Gross Unrealized Loss, Before Tax	(118)	(22)
Investments, Fair Value Disclosure	1,306	1,584
Cash Equivalents, Marketable Securities and Other Investments, Amortized Cost Basis	3,150	2,136
Cash Equivalents, Marketable Securities and Other Investments, Accumulated Gross Unrealized Gain, Before Tax	81	119
Cash Equivalents, Marketable Securities and Other Investments, Accumulated Gross Unrealized Loss, Before Tax	(118)	(22)
Cash Equivalents, Marketable Securities and Other Investments, Fair Value	3,113	2,233
Long-term Debt	(16,697)	(16,410)
Long Term Debt, Accumulated Gross Unrealized Gain, Before Tax	384	7
Long Term Debt, Accumulated Gross Unrealized Loss, Before Tax	(1,326)	(2,258)
Long-term Debt, Fair Value	(17,639)	(18,661)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	380	168
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	(656)	(419)
Derivative Assets (Liabilities), at Fair Value, Net	(276)	(251)
Long Term Debt, Accumulated Fair Value Adjustment	68	1
Derivative, Amount of Hedged Item	2,790	3,490
Interest Rate Contract [Member]
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	194	8
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	(331)	(283)
Derivative Assets (Liabilities), at Fair Value, Net	(137)	(275)
Foreign Exchange Contract [Member]
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	53	101
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	(39)	(21)
Derivative Assets (Liabilities), at Fair Value, Net	14	80
Commodity Contract [Member]
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	133	59
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	(286)	(115)
Derivative Assets (Liabilities), at Fair Value, Net	(153)	(56)
US Treasury and Government [Member]
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	458	533
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	37	33
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(33)	(11)
Debt Securities, Available-for-sale	462	555
Corporate Debt Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	877	944
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	43	80
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(84)	(10)
Debt Securities, Available-for-sale	836	1,014
Held-to-maturity Securities
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents, at Carrying Value	1,233	220
Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax	0	0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Fair Value	1,233	220
Money Market Funds
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents, at Carrying Value	573	408
Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax	0	0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Fair Value	$ 573	$ 408

Debt Investments (Details)

Debt Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Proceeds from sales of available-for-sale securities	$ 248	$ 159
Gross realized gains	16	6
Available-for-sale Securities, Gross Realized Losses	(7)	$ (5)
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost	12
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value	11
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost	363
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value	340
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost	467
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value	437
Debt Securities, Available-for-sale, Allocated and Single Maturity Date, Maturity, after 10 Years, Amortized Cost	493
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value	510
Debt Securities, Available-for-sale, Amortized Cost	1,335		$ 1,477
Debt Securities, Available-for-sale	$ 1,298		$ 1,569

Temporarily Impaired Securities

Temporarily Impaired Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value	$ 516		$ 134
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(88)		(6)
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	34		75
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(29)		(15)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	550		209
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(117)		(21)
Equity Securities, Net Unrealized Gain (Loss)	1	$ 5
Equity securities 3	8		15
Equity Securities without Readily Determinable Fair Value, Amount	190		189
US Treasury and Government [Member]
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value	109		55
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(22)		(3)
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	10		23
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(11)		(8)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	119		78
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(33)		(11)
Corporate Debt Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value	407		79
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(66)		(3)
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	24		52
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(18)		(7)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	431		131
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ (84)		$ (10)

Notional Amounts (Details)

Notional Amounts (Details) $ in Millions	Mar. 31, 2020USD ($)BoeMWh	Dec. 31, 2019USD ($)MWhBoe
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount	$ 921	$ 922
Interest Rate Swap [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount	105	145
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount	3,472	6,253
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount	$ 5,706	$ 5,567
Commodity Contract Hydrocarbons | Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Nonmonetary Notional Amount | Boe	20,000,000	6,100,000
Commodity Contract Hydrocarbons | Not Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Nonmonetary Notional Amount | Boe	400,000	100,000
Commodity Contract Power | Not Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Nonmonetary Notional Amount | MWh	80,500	87,500

Schedule of Fair Value of Deriv

Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Derivatives, Fair Value [Line Items]
Derivative Liability, Collateral, Right to Reclaim Cash, Offset	$ 6	$ 5
Derivative Asset, Collateral, Obligation to Return Cash, Offset	1	3
Fair Value, Inputs, Level 2 [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	696	274
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(316)	(106)
Derivative Asset	380	168
Derivative Liability, Fair Value, Gross Liability	971	530
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(315)	(111)
Derivative Liability	656	419
Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	450	198
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(271)	(77)
Derivative Asset	179	121
Derivative Liability, Fair Value, Gross Liability	544	203
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(271)	(82)
Derivative Liability	273	121
Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	246	76
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(45)	(29)
Derivative Asset	201	47
Derivative Liability, Fair Value, Gross Liability	427	327
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(44)	(29)
Derivative Liability	383	298
Other Current Assets [Member] | Interest Rate Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	192	21
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(156)	(13)
Derivative Asset	36	8
Other Current Assets [Member] | Foreign Exchange Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	109	105
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(80)	(36)
Derivative Asset	29	69
Other Current Assets [Member] | Foreign Exchange Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	65	44
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(41)	(12)
Derivative Asset	24	32
Other Current Assets [Member] | Commodity Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	82	44
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(32)	(25)
Derivative Asset	50	19
Other Current Assets [Member] | Commodity Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	22	18
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(4)	(3)
Derivative Asset	18	15
Other Current Assets [Member] | Interest Rate Swap [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement		14
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset		(14)
Derivative Asset		0
Deferred charges and other assets [Member] | Interest Rate Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	158
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	0
Derivative Asset	158
Deferred charges and other assets [Member] | Commodity Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	67	28
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(3)	(3)
Derivative Asset	64	25
Deferred charges and other assets [Member] | Commodity Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	1
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	0
Derivative Asset	1
Accrued and Other Current Liabilities [Member] | Interest Rate Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	156	23
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(156)	(13)
Derivative Liability	0	10
Accrued and Other Current Liabilities [Member] | Foreign Exchange Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	88	46
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(80)	(36)
Derivative Liability	8	10
Accrued and Other Current Liabilities [Member] | Foreign Exchange Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	71	23
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(40)	(12)
Derivative Liability	31	11
Accrued and Other Current Liabilities [Member] | Commodity Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	152	95
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(32)	(29)
Derivative Liability	120	66
Accrued and Other Current Liabilities [Member] | Commodity Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	24	17
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(4)	(3)
Derivative Liability	20	14
Accrued and Other Current Liabilities [Member] | Interest Rate Swap [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		136
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset		(14)
Derivative Liability		122
Other Noncurrent Obligations [Member] | Interest Rate Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		1
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset		0
Derivative Liability		1
Other Noncurrent Obligations [Member] | Interest Rate Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	331
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	0
Derivative Liability	331
Other Noncurrent Obligations [Member] | Commodity Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	148	38
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(3)	(4)
Derivative Liability	145	34
Other Noncurrent Obligations [Member] | Commodity Contract [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	1	1
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	0	0
Derivative Liability	$ 1	1
Other Noncurrent Obligations [Member] | Interest Rate Swap [Member] | Fair Value, Inputs, Level 2 [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		150
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset		0
Derivative Liability		$ 150

Effect of Derivative Instrument

Effect of Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	$ (32)	$ 73
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	17	(11)
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	(32)	73
Gain (Loss) on Hedging Activity	31	33
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0	0
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	(14)	(44)
Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0	0
Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	(6)	0
Interest Rate Contract [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0	0
Interest Rate Contract [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	24	0
Interest Rate Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0	(106)
Interest Rate Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	0	0
Excluded Components [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax	0	0
Excluded Components [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member] | Cumulative Translation Adjustments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	3	0
Excluded Components [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Cumulative Translation Adjustments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	22	86
Excluded Components [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax	14	25
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0	0
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	(19)	(32)
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	8	7
Gain (Loss) on Hedging Activity	4	8
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0	1
Gain (Loss) on Hedging Activity	0	0
Foreign Exchange Contract [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	22	30
Gain (Loss) on Hedging Activity	0	0
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	0	0
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member] | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	11	(12)
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	(87)	55
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	$ (11)	$ 0

Expected Reclassification (Deta

Expected Reclassification (Details) $ in Millions	Mar. 31, 2020USD ($)
Interest Rate Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net	$ 1
Commodity Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months	(32)
Foreign Exchange Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	9
Excluded Components [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedge Gain (Loss) to be Reclassified During Next 12 Months, Excluded Components, Net	$ 10

FAIR VALUE MEASUREMENTS (Summar

FAIR VALUE MEASUREMENTS (Summary of Recurring Measured Fair Values) (Details) - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities 3	$ 8	$ 15
Debt Securities, Available-for-sale	1,298	1,569
Long-term debt including debt due within one year 6	17,639	18,661
US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	462	555
Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	836	1,014
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	696	274
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	1	21
Equity securities 3	8	15
Total assets at fair value	3,809	2,507
Long-term debt including debt due within one year 6	17,639	18,661
Total liabilities at fair value	18,610	19,191
Fair Value, Recurring [Member] | Held-to-maturity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents 1	1,233	220
Fair Value, Recurring [Member] | Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents 1	573	408
Fair Value, Recurring [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	350	35
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	487	310
Fair Value, Recurring [Member] | Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	174	149
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	159	69
Fair Value, Recurring [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	172	90
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	325	151
Fair Value, Recurring [Member] | US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	462	555
Fair Value, Recurring [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	836	1,014
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Equity securities 3	8	15
Total assets at fair value	59	60
Long-term debt including debt due within one year 6	0	0
Total liabilities at fair value	18	14
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Held-to-maturity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents 1	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents 1	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	0	0
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	0	0
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	31	23
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	18	14
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	20	22
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	1	21
Equity securities 3	0	0
Total assets at fair value	3,750	2,447
Long-term debt including debt due within one year 6	17,639	18,661
Total liabilities at fair value	18,592	19,177
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Held-to-maturity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents 1	1,233	220
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents 1	573	408
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	350	35
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	487	310
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	174	149
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	159	69
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	141	67
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	307	137
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	462	555
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	816	992
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Private Market Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	114	117
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Real Estate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	22	18
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Private Market Securities and Real Estate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments	$ 66	$ 76

FAIR VALUE MEASUREMENTS FAIR VA

FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS (Summary of Nonrecurring Measured Fair Values) (Details) - Manufacturing Facility [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges		$ 12
Packaging & Specialty Plastics [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges	$ 6

RELATD PARTY TRANSACTIONS (Deta

RELATD PARTY TRANSACTIONS (Details) - The Dow Chemical Company [Domain] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Dow Inc. [Member]
Cash Dividends Paid to Related Party	$ 643	$ 0
DowDuPont [Member]
Cash Dividends Paid to Related Party		535
DuPont and its Affiliates [Member]
Net sales		12
Related Party Costs		$ 9

SEGMENTS AND GEOGRAPHIC REGIO_3

SEGMENTS AND GEOGRAPHIC REGIONS Segment Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Net sales	$ 9,770	$ 10,969
Business Acquisition, Pro Forma Revenue		11,016
Equity in losses of nonconsolidated affiliates	(89)	(14)
Operating EBIT	843
Pro Forma Operating EBIT		1,143
Packaging & Specialty Plastics [Member]
Segment Reporting Information [Line Items]
Net sales	4,609	5,138
Business Acquisition, Pro Forma Revenue		5,138
Equity in losses of nonconsolidated affiliates	5	38
Operating EBIT	580
Pro Forma Operating EBIT		690
Industrial Intermediates & Infrastructure [Member]
Segment Reporting Information [Line Items]
Net sales	3,045	3,480
Business Acquisition, Pro Forma Revenue		3,489
Equity in losses of nonconsolidated affiliates	(76)	(48)
Operating EBIT	175
Pro Forma Operating EBIT		277
Performance Materials & Coatings [Member]
Segment Reporting Information [Line Items]
Net sales	2,065	2,282
Business Acquisition, Pro Forma Revenue		2,320
Equity in losses of nonconsolidated affiliates	1	0
Operating EBIT	162
Pro Forma Operating EBIT		271
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Net sales	51	69
Business Acquisition, Pro Forma Revenue		69
Equity in losses of nonconsolidated affiliates	(19)	(4)
Operating EBIT	$ (74)
Pro Forma Operating EBIT		$ (95)

SEGMENTS AND GEOGRAPHIC REGIO_4

SEGMENTS AND GEOGRAPHIC REGIONS EBIT Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting [Abstract]
Income from continuing operations, net of tax	$ 258	$ 156
Provision for income taxes	138	141
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	396	297
Interest Income, Other	15	18
Interest Expense, Debt	215	241
Other Nonrecurring (Income) Expense	(247)	(558)
Operating EBIT	$ 843
Pro Forma Adjustments		65
Pro Forma Operating EBIT		$ 1,143

SEGMENTS AND GEOGRAPHIC REGIO_5

SEGMENTS AND GEOGRAPHIC REGIONS Significant Items (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Business Combination, Integration Related Costs	$ (65)	$ (402)
Restructuring Charges	(96)	(156)
Gain (Loss) on Extinguishment of Debt	(86)
Other Nonrecurring (Income) Expense	(247)	(558)
Packaging & Specialty Plastics [Member]
Segment Reporting Information [Line Items]
Business Combination, Integration Related Costs	0	0
Restructuring Charges	(6)	(13)
Gain (Loss) on Extinguishment of Debt	0
Other Nonrecurring (Income) Expense	(6)	(13)
Industrial Intermediates & Infrastructure [Member]
Segment Reporting Information [Line Items]
Business Combination, Integration Related Costs	0	0
Restructuring Charges	0	0
Gain (Loss) on Extinguishment of Debt	0
Other Nonrecurring (Income) Expense	0	0
Performance Materials & Coatings [Member]
Segment Reporting Information [Line Items]
Business Combination, Integration Related Costs	0	0
Restructuring Charges	0	0
Gain (Loss) on Extinguishment of Debt	0
Other Nonrecurring (Income) Expense	0	0
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Business Combination, Integration Related Costs	(65)	(402)
Restructuring Charges	(90)	(143)
Gain (Loss) on Extinguishment of Debt	(86)
Other Nonrecurring (Income) Expense	$ (241)	$ (545)